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Abstract
Stepped wedge cluster randomized trials (SW-CRTs) have become increasingly popular and
are used for a variety of interventions and outcomes, often chosen for their feasibility ad-
vantages. SW-CRTs must account for time trends in the outcome because of the staggered
rollout of the intervention inherent in the design. Robust inference procedures and non-
parametric analysis methods have recently been proposed to handle such trends without
requiring strong parametric modeling assumptions, but these are less powerful than model-
based approaches. We propose several novel analysis methods that reduce reliance on mod-
eling assumptions while preserving some of the increased power provided by the use of mixed
effects models. In one method, we use the synthetic control approach to find the best match-
ing clusters for a given intervention cluster. This approach can improve the power of the
analysis but is fully non-parametric. Another method makes use of within-cluster crossover
information to construct an overall estimator. We also consider methods that combine these
approaches to further improve power. We test these methods on simulated SW-CRTs and
identify settings for which these methods gain robustness to model misspecification while
retaining some of the power advantages of mixed effects models. Finally, we propose avenues
for future research on the use of these methods; motivation for such research arises from
their flexibility, which allows the identification of specific causal contrasts of interest, their
robustness, and the potential for incorporating covariates to further increase power. Inves-
tigators conducting SW-CRTs might well consider such methods when common modeling
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assumptions may not hold.
Keywords: Stepped wedge, cluster randomized trials, mixed effects models, permutation
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1 Background
Cluster randomized trials (CRTs) have become a popular form of randomized trial, with
many practical benefits, reflecting the necessity of implementing some interventions on clus-
ters of individuals, and statistical benefits, such as accounting for interference between in-
dividuals.1–3 The causal estimand of interest and the overall risk-benefit profile of the trial
can also affect the choice to use cluster randomization.4–6 While parallel-arm CRTs are the
most common, stepped wedge CRTs (SW-CRTs) have also become more common, being
used for a variety of interventions.7–11 In SW-CRTs, each cluster begins in the control arm.
At designated time points, a cluster or clusters “cross over” to the intervention arm and
remain in that arm for the duration of the study. The order in which clusters cross over to
the intervention is randomized.12,13
SW-CRTs are especially valuable when the intervention cannot be implemented in a
large number of clusters simultaneously due to practical constraints.4,7,8,14 They can also
be useful when the communities who will participate in the trial wish to ensure that all
clusters receive the intervention before the end of the trial.7,8,14,15 In particular, the design
can be useful for assessing complex health interventions and for evaluating effectiveness of
implementation.16,17 There are, however, drawbacks to the design, and some of the benefits
of the design may be achieved with parallel-arm CRT designs as well.18 Ethical arguments
both for and against SW-CRTs have been made in various contexts, including arguments
about the role of clinical equipoise.7,19,20 And while the design may yield increased power
over parallel-arm CRTs, this depends on both a large number of measurements over time and
a statistically valid analysis method that controls for confounding of the treatment effect by
time.13,17–19,21,22 Because more clusters are assigned to the intervention at later time points,
the effect of time on the outcome must be accounted for in order to obtain unbiased or
consistent treatment effects.10,19,23 Additionally, SW-CRTs with a relatively small number
of clusters can be underpowered to detect effects, at least without making strong modeling
assumptions.24
The most common method for analyzing SW-CRTs is the use of a linear or generalized
linear mixed effects model. As described by Hussey and Hughes, this model can include a
random intercept for each cluster and a fixed effect for time periods.12 This form of the model
assumes that the additive effect for each time period is the same across clusters. A more
general model proposed by Hooper et al. adds an independent random intercept for cluster-
period.25 This, however, still assumes that the time trend does not vary systematically
among clusters. In addition, both models require the specification of the distribution of
these random intercepts. Misspecified random effects distributions can affect inference on the
fixed effect estimators (i.e., the treatment effect estimator), although the effect on fixed effect
estimates themselves is unclear and context-dependent.24,26–31 Finally, for the relatively small
number of clusters in many SW-CRTs, asymptotic inference may not be appropriate.32,33
Various methods have been proposed to remedy these issues. One approach, proposed by
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Wang and De Gruttola and by Ji et al., uses permutation tests to ensure nominal Type I Error
and accurate inference, even for small numbers of clusters, as long as the effect estimate is
unbiased.32,33 In the longitudinal context more generally, linear and generalized linear mixed
effects models have been proposed that allow for flexible semi-parametric specification of the
random effects distributions.34–36 The operating characteristics of these different approaches
to robust mixed effect model fitting have not been well-studied for SW-CRTs. Scott et al.
have proposed the use of generalized estimating equations with finite-sample corrections to
avoid the need to specify random effects distributions.37 Thompson et al. recently proposed
a non-parametric analysis method that uses within-period (“vertical”) comparisons.38 They
propose conducting inference by permutation tests as well to ensure nominal Type I Error
and confidence interval coverage. They demonstrate through simulation that this method has
no or low bias and nominal Type I Error and coverage.38 Finally, Hughes et al. have proposed
a robust inference method for SW-CRTs using vertical comparisons that gives a closed-form
standard deviation estimate.39 However, both of these vertical methods can suffer from
greatly reduced power compared to the parametric mixed effects models. Because SW-CRTs
often have relatively few clusters, this can result in analyses that are highly underpowered
to detect meaningful treatment effects.
In Section 2, we propose novel non-parametric methods to analyze SW-CRTs. In the first
method, we, like Thompson et al., use within-period comparisons to avoid the problem of
misspecification of time effects and cluster random intercept distributions. We incorporate
the synthetic control procedure to match treated clusters with untreated clusters that are
likely to be most similar. Synthetic controls are a relatively new but increasingly popular
method for causal inference most common in the econometrics literature.40–42 The approach
is generally used when there is one treated cluster and a “donor pool” of untreated clusters,
with outcome data both before and after the treatment began. The method finds the linear
combination of untreated clusters that most closely matches the pre-treatment outcomes of
the treated cluster. The causal effect estimate is then some contrast of the treated cluster’s
post-treatment outcomes and that linear combination of the outcomes of the untreated clus-
ters in the same period.41 We use this approach, somewhat akin to matching or covariate
adjustment in parallel-arm clinical trials, to improve the power of the analysis.
The second method we propose uses the within-cluster between-period (“horizontal”)
comparisons that are inherent in SW-CRT and other crossover designs to improve the power
of non-parametric approaches.19,24 This crossover method compares the between-period effect
of clusters crossing over to that of clusters in the control arm in both periods (or in the
intervention arm in both periods).
We also propose two ways of combining these methods. In one, we use synthetic controls
to find the best-matching clusters for the crossover approach. In the other, we form an
ensemble estimator by averaging the estimators obtained from the synthetic control and
crossover methods.
In Section 3, we compare by simulation the operating characteristics of these novel meth-
ods, the mixed effects models with both asymptotic and permutation-based inference, and
the non-parametric within-period model, for both risk difference and odds ratio effect scales.
We also apply these novel methods to a SW-CRT on the effects of diagnostic tests on tuber-
culosis outcomes reported by Trajman et al.,43 and compare the results to those for existing
methods.
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Finally, in Section 4, we discuss the implications of these results for those designing and
analyzing SW-CRTs. We also propose future research directions to better understand the
relative performance of the methods considered here, as well as to better understand in which
settings a SW-CRT may or may not be a reasonable design.
2 Methods
In this section, we propose several novel methods of analysis for SW-CRTs: a synthetic
control-based method, a crossover-based method, a combination method, and an ensemble
method. These methods have flexible weighting schemes that allow the method to be tailored
to particular situations. These methods do not rely on any particular distribution of the
outcome data and can be used to estimate any causal contrast of interest.
2.1 Setting and Notation
Consider a SW-CRT with I clusters with outcome measurements in each of J periods.
Denote by Yi,j the mean outcome for all K measured individuals in cluster i in period j (K
can be fixed or vary by cluster-period). Let Xi,j denote the intervention status of cluster
i in period j, with Xi,j = 1 indicating that the cluster is on intervention and Xi,j = 0
indicating that the cluster is on control. For each period j, let I0,j = {i : Xi,j = Xi,j−1 = 0},
I1,j = {i : Xi,j = 1, Xi,j−1 = 0}, and I2,j = {i : Xi,j = Xi,j−1 = 1}, the set of clusters on
control in both periods j and j − 1, crossing over in period j, and on intervention in both
periods j and j − 1, respectively. Denote the number of clusters in each of these sets by
n0,j , n1,j, and n2,j , respectively. We assume that each cluster only crosses over once; once a
cluster is on intervention, it remains so for the rest of the periods under study. We assume
throughout that the order of crossover is determined randomly. For each cluster i, let ji be
the last period for which it is on control (define ji = 0 if cluster i is on intervention in period
1); then ji + 1 is the first period on intervention for cluster i. For any period j, denote by
Y·j the expected value of the outcome (marginal across clusters) in period j in the absence
of intervention. That is, Y·j = E[Yi,j|Xi,j = 0] for any cluster i.
Let g(y1, y2) be the contrast of interest. For example, for binary outcomes, the risk
difference is given by g(y1, y2) = y1 − y2 and the log odds ratio is given by g(y1, y2) =
log
(
y1/(1−y1)
y2/(1−y2)
)
. Although binary outcomes are more common in SW-CRTs,10 contrasts on
continuous and count outcomes may be specified as well.
2.2 Existing methods for comparison
We compare the performance of these novel analysis methods with that of three current
approaches for the analysis of SW-CRTs: two mixed effects model specifications (each with
both asymptotic and exact inference) and the non-parametric within-period method.
First, we consider the commonly-used mixed effects model with a random intercept for
cluster and fixed effects for time:
h(E[Yi,j]) = µ+ αi + θj +Xi,jβ, (1)
4
where h is the link function, µ is the global mean under control in period 1, αi
iid
∼ N(0, τ 2),
and θ1 = 0 for identifiability.
12 Generalized linear mixed model theory can be used for
asymptotic inference, and permutation tests (and associated confidence intervals) can be
used for exact inference with this model.32,33
Second, we consider the mixed effects model with an additional cluster-period random
intercept:
h(E[Yi,j]) = µ+ αi + θj + ηi,j +Xi,jβ, (2)
where h is the link function, µ is the global mean under control in period 1, αi
iid
∼ N(0, τ 2),
θ1 = 0 for identifiability, ηi,j
iid
∼ N(0, ν2), and ηi,j ⊥ αi for all i, j.
25 Inference can proceed on
an asymptotic or exact basis as above.32
Third, we consider the non-parametric within-period method. In this method, for each
period j where there are clusters on control and on intervention, a period-specific effect
estimate is calculated by comparing the mean outcome of clusters on intervention (i ∈
I1,j ∪ I2,j) to the mean outcome of clusters on control (i ∈ I0,j):
βˆj = g
(∑
i∈I1,j∪I2,j
Yi,j
n1,j + n2,j
,
∑
i∈I0,j
Yi,j
n0,j
)
. (3)
The period-specific effect estimates are combined using an inverse-variance weighted average
to obtain an overall estimated intervention effect:
βˆ =
∑
j: 0<n0,j<I
wj
w
βˆj , (4)
where wj =
[(
(n0,j−1)s20,j+(n1,j+n2,j−1)s
2
1,j
J−2
)(
1
n0,j
+ 1
n1,j+n2,j
)]−1
, w =
∑
j:0<n0,j<I
wj, and s
2
0,j
and s21,j are the empirical variances of the Yi,j values for clusters on control and on inter-
vention, respectively, for period j.38 A schematic representation of this estimation method
is given in Figure 1a. Exact inference can proceed using permutation tests.38
2.3 Synthetic control method
Our first proposed method uses the synthetic control procedure developed by Abadie et al.
to estimate the effect of treatment for each intervention cluster-period.41 Similar to the non-
parametric within-period method proposed by Thompson et al., this novel method constructs
vertical comparisons and then uses a weighted average of these comparisons as an overall
effect estimate.38
1. For each period j where there are clusters on control and on intervention, for each
cluster i on intervention (i ∈ I1,j ∪ I2,j), we construct a synthetic control estimator
Zi,j, using the procedure outlined by Abadie et al.
41 The synthetic control for cluster
i in period j is a weighted average of the outcomes of the clusters on control in period
j: Zi,j =
∑n0,j
n=1 vi,j,nYmn,j, where m1, . . . , mn0,j are the clusters on control in period
j. The weights, vi,j,n, are selected by the synthetic control procedure to minimize the
mean squared difference between the synthetic control for periods where cluster i was
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on control and the true outcome for cluster i in that period subject to the constraints
that the weights are nonnegative and sum to one. That is, they minimize:
MSPEi,j =
∑
j′: Xi,j′=0

Yi,j′ − ∑
n: Xmn,j′=0
vi,j,nYmn,j′


2
. (5)
See the proof of Theorem 1 in Appendix A for details. If specific cluster-level covariates
are known, they can be included in estimation of the synthetic control as well.41 When
the synthetic control procedure does not converge or there are no pre-intervention
periods for this cluster, the unweighted mean of the outcomes of clusters on control
in period j is used as Zi,j. In these cases, the period-specific effect estimator is the
same as that for the non-parametric within-period method described above, and so the
properties of that estimator hold.
2. For each intervention cluster i, for each period j where Xi,j = 1 and n0,j ≥ 1, we
construct an estimator:
βˆi,j = g(Yi,j, Zi,j) (6)
3. We find an overall estimator via a weighted average of these cluster-period-specific
estimators:
βˆ =
∑
j: 0<n0,j<I
∑
i∈I1,j∪I2,j
wi,j
w
βˆi,j , (7)
where wi,j ≥ 0 and w =
∑
j: 0<n0,j<I
∑
i∈I1,j∪I2,j
wi,j.
A schematic representation of this estimation method is given in Figure 1b.
2.3.1 Inferential procedure
A permutation test can be used for exact inference, as for mixed effects models and the non-
parametric within-period method.32,38 The standard permutation test approach is used: P
random permutations of the crossover order are generated and an estimate of the treatment
effect is obtained from each permutation using the estimation procedure described above.
The true estimate βˆ is compared to these estimates and the p-value for the null hypothesis
of no effect of treatment is given by the proportion of the P estimates for which
∣∣∣βˆp∣∣∣ ≥ ∣∣∣βˆ∣∣∣.
This approach matches inferential methods for synthetic control estimators, which rely on
permuting the treatment indicator of units and estimating placebo synthetic control esti-
mators to derive the null distribution of the estimator.41,42,44 To obtain confidence intervals,
the permutation test can be inverted in the standard way.
2.3.2 Computation
This procedure is implemented in the R code available at:
https://github.com/leekshaffer/SW-CRT-analysis.
This implementation uses the synth function from the Synth package to obtain the synthetic
control weights vi,j,n.
45
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2.3.3 Properties of the estimator
In a SW-CRT with a randomized order of crossover, the synthetic control estimator Zi,j is an
unbiased estimate of the expected outcome under control, Y·j, if the underlying cluster-level
outcome distribution is symmetric around some global mean outcome vector across peri-
ods; see Theorem 1 in Appendix A. If the individual-level outcomes have cluster-conditional
expectations that are symmetric around a global mean vector, the estimator is asymptoti-
cally unbiased as the number of subjects with measured outcomes per cluster increases; see
Corollary 1. Thus, for any weights independent of the outcomes, the SC estimator using
the risk difference is unbiased or asymptotically unbiased under these conditions if there is
a common risk difference across cluster-periods. See Theorem 2 and Corollary 2. Note that
all of the assumptions of Corollary 2 are satisfied under the mixed effects models described
in Section 2.2 with an identity link function as long as the random effects are independent
and identically distributed following a normal (or any other symmetric) distribution.
2.3.4 Selecting weights
The weights for combining the cluster-period-specific estimators, wi,j, can be selected on the
basis of two primary goals: (1) minimizing the variance of the overall estimator βˆ; or (2)
estimating a specific causal contrast when treatment effects may not be equal across clusters
and time periods.
For the first goal, a natural approach is to follow the synthetic control literature on
evaluating the accuracy of the synthetic control estimator or combining multiple synthetic
control estimators by using the inverse of the mean squared prediction error (MSPE) values
for each synthetic control estimator.46–48 For cluster i in period j, the MSPE of the synthetic
control fit is given by equation (5). In the SW-CRT setting, however, the MSPE values are
not directly comparable as different synthetic control estimators have a different number of
pre-intervention periods that contribute. By contrast, the MSPE values will be comparable
for intervention clusters that begin treatment in the same period, as these clusters will always
have the same number of pre-intervention periods, regardless of which of their intervention
periods are being examined. We therefore propose to weight the βˆi,j values by the inverse-
MSPE within each set of intervention clusters that cross over in the same period, and then
weight across these sets equally. That is, for each (i, j) such that Xi,j = 1, set weights
proportional to:
wi,j =
MSPE−1i,j∑
(i′,j′):i′∈I1,j ,Xi′,j′=1
MSPE−1i′,j′
, (8)
where MSPEi,j is the MSPE of the synthetic control estimation procedure that produces
Zi,j.
For the second goal of weighting, the weighting approach will depend on the causal esti-
mand of interest. If, for example, investigators are only interested in the effect of intervention
in the first period of its introduction to any cluster, they may select as weights:
wi,j =
{
1, i ∈ I1,j
0, otherwise
, (9)
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that is, only using the βˆi,j estimates for the first period on intervention for each cluster. We
do not present results on this approach here, but further research is needed to understand
the causal estimands that may be of interest when the treatment effect cannot be assumed to
be constant across clusters and periods. In this way, the weights also aid interpretability of
the estimator, as it is clear which clusters and periods are considered and how much weight
is given to each.
2.4 Crossover method
The second novel method seeks to improve on the power of the non-parametric within-
period method by incorporating horizontal comparisons at the time of crossover. There is
substantial literature on the value of within-subject analysis methods and methods combining
within- and between-subject analyses for individual randomized crossover trials, especially
in the absence of anticipation, lag, or carryover effects of treatment.49–52 The method we
propose for SW-CRTs compares the mean contrast between the last control period and the
first intervention period for each cluster crossing over from one period to the next to the mean
contrast in those same periods among clusters on control in both periods. Since standard
mixed effects models give a large weight to horizontal comparisons,24 the crossover approach
may recover some of the power of mixed effects models while preserving the robustness of
non-parametric estimation. The procedure is as follows:
1. For each cluster i and period j > 1, defineDi,j ≡ g(Yi,j, Yi,j−1), the contrast in outcomes
in cluster i between consecutive periods. E.g., for a risk difference analysis, Di,j =
Yi,j − Yi,j−1, the difference in outcomes between consecutive periods.
2. For each period j > 1 with clusters on both intervention and control, estimate the
treatment effect for period j by:
βˆj =
∑
i∈I1,j
Di,j
n1,j
−
∑
i∈I0,j
Di,j
n0,j
. (10)
If the treatment effect is assumed to be constant across time, an alternate estimator is
given by:
β˜j =
∑
i∈I1,j
Di,j
n1,j
−
∑
i∈I0,j∪I2,j
Di,j
n0,j + n2,j
. (11)
This alternative compares the change in outcome for the clusters which cross over to
the change for clusters which either remain on control in both periods or remain on
intervention in both periods.
3. Construct an overall estimator with a weighted average of period-specific estimators:
βˆ =
∑
j>1: 0<n0,j ,n1,j<I
wj
w
βˆj , or β˜ =
∑
j>1: 0<n1,j<I
w′j
w′
β˜j , (12)
where wj, w
′
j ≥ 0 and w =
∑
j>1: 0<n0,j ,n1,j<I
wj and w
′ =
∑
j>1: 0<n1,j<I
w′j.
A schematic representation of this estimation method is given in Figure 1c.
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2.4.1 Inferential procedure
A permutation test can again be used for hypothesis testing and to obtain confidence in-
tervals. The procedure is the same as the inferential procedure for the synthetic control
estimator, detailed in Section 2.3.1.
2.4.2 Computation
This procedure is implemented in the R code available at:
https://github.com/leekshaffer/SW-CRT-analysis.
2.4.3 Properties of the estimator
For the risk difference, g(y1, y2) = y1−y2, any of these crossover estimates are unbiased esti-
mates of the true risk difference β, under a randomized crossover order and the assumption
of a constant β across clusters and periods. See Theorem 3 in Appendix A. The controls-only
estimator βˆ is unbiased for the intervention effect in the first period on intervention if that
effect is constant across clusters. See Corollary 3 in Appendix A.
2.4.4 Selecting weights
As for the synthetic control estimator, the weights can be selected either to minimize the
variance of the overall estimator or to ensure proper estimation of a specific causal estimand.
For the latter, again, this will depend on the specific estimand of interest, e.g., to match a
target population of clusters.
To minimize the variance of the overall estimator, the weights may depend on the variance
of the cluster-level outcome for each cluster-period. If all of these variances are assumed to
be the same (i.e., all have the same subject-level variance and the same number of subjects),
then the weight should depend only on the number of clusters in each treatment condition
in that period. That is, we weight each estimator βˆj by wj =
(
1
n0,j
+ 1
n1,j
)−1
, the harmonic
mean of the number of clusters used to estimate the consecutive-period control effect and
the number of clusters used to estimate the crossover effect. For β˜j , where the clusters which
were on intervention in both periods j and j − 1 are used as control crossovers as well, we
weight by w′j =
(
1
n0,j+n2,j
+ 1
n1,j
)−1
. Note that when the same number of clusters cross over
at each time point, w′j is constant across j, while wj decreases as j increases.
2.5 Crossover-synthetic control method
A third potential method combines these two approaches by finding a synthetic control for
the horizontal crossover contrast and comparing the intervention horizontal contrast to this
synthetic control. This may combine the benefits of using horizontal comparisons with the
benefits of synthetic control-based matching between clusters.
1. For each cluster i and period j > 1, defineDi,j ≡ g(Yi,j, Yi,j−1), the contrast in outcomes
in cluster i between consecutive periods. E.g., for a risk difference analysis, Di,j =
Yi,j − Yi,j−1, the difference in outcomes between consecutive periods.
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2. For each cluster i ∈ I∗ ≡ {i : ji + 1 > 1 ∩ n0,ji+1 > 0}, the set of clusters that
begin intervention in a period after period 1 that has clusters on control, construct
a synthetic control horizontal contrast estimator Ci, using the procedure outlined by
Abadie et al.41 For cluster i, which crosses over in period j, the synthetic control is a
weighted average of the horizontal contrasts of the clusters on control in both periods
j − 1 and j: Ci =
∑n0,j
n=1 vi,nDmn,j , where m1, . . . , mn0,j are the clusters on control in
both periods. The weights are selected by the synthetic control procedure to minimize
the mean squared difference between the synthetic control for periods j′ where cluster
i ∈ I0,j′ and the true horizontal contrast for cluster i in that period subject to the
constraints that the weights are nonnegative and sum to one. When the synthetic
control procedure does not converge or there are no pre-crossover consecutive period
contrasts for this cluster, the unweighted mean of the values Di′,j for i
′ ∈ I0,j is used
as Ci.
3. For each cluster i ∈ I∗, we construct an estimator using its crossover effect in period
j:
βˆi = Di,j − Ci. (13)
4. We find an overall estimator via a weighted average of these cluster-specific estimators:
βˆ =
∑
i∈I∗
wi
w
βˆi, (14)
where w =
∑
i∈I∗ wi.
A schematic representation of this estimation method is given in Figure 1d. Note that
this procedure is the same as that for the synthetic control method, but using Di,j as the
“outcomes” in place of Yi,j.
2.5.1 Inferential procedure
The inferential procedure for the synthetic control estimator, detailed in Section 2.3.1, can
again be used here for exact inference.
2.5.2 Computation
This procedure is implemented in the R code available at:
https://github.com/leekshaffer/SW-CRT-analysis.
This implementation uses the synth function from the Synth package to obtain the synthetic
control weights vi,n.
45
2.5.3 Selecting weights
As for the synthetic control estimator, a natural approach to minimize the variance of the
overall estimator is to use weights inversely proportional to the MSPE of the synthetic
control fits. Again, though, because the number of pre-crossover periods varies, these are
only comparable among clusters which cross over in the same period. So we propose to
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weight the βˆi values by the inverse-MSPE within each set of intervention clusters that cross
over in the same period, and then weight across these sets equally. That is, for each i, set:
wi =
MSPE−1i∑
i′∈I1,ji+1
MSPE−1i′
, (15)
where MSPEi is the MSPE of the synthetic control estimation procedure that produces Zi.
2.6 Ensemble method
Finally, we consider an ensemble method that averages the estimators of previously-described
methods. For any unbiased and/or consistent estimators, a weighted average of those esti-
mators with weights that do not depend on the data will also be unbiased/consistent. If the
covariance of the estimators is small enough compared to the variances, it may also reduce
the variance of the estimator. In Appendix B, we derive the variances and covariance of the
non-parametric within-period and crossover estimators under a simplified data-generating
process. We then demonstrate that in a simplified data-generating setting, when the dif-
ference in the mean outcome between clusters is relatively small, compared to the variabil-
ity within clusters, a simple mean of the non-parametric within-period estimator and the
crossover estimator has a lower variance than either estimator on its own.
There is no known analytic formula for the variance of the synthetic control estimator,
although we expect (and simulation results presented below suggest) the synthetic control
estimator to have lower variance than the non-parametric within-period estimator when the
synthetic control matching performs well. Since the synthetic control and non-parametric
within-period estimators are both vertical methods of analysis, we consider here an ensemble
estimator that is a simple mean of the synthetic control estimator and the crossover estimator.
That is,
βˆENS =
1
2
βˆSC +
1
2
βˆCO, (16)
where βˆSC is a synthetic control estimator and βˆCO is a crossover estimator.
Note that many other ensemble estimators could be constructed, using different analysis
methods and different weights. In addition, within-period ensembles may be constructed
and then combined across periods (e.g., take the average of the SC estimators within each
period j and average those with the CO estimator for period j, and then combine across
periods to target a specific causal estimand). We use this simple version here to demonstrate
the concept of the ensemble method and show its potential to improve power, but different
ensembles will have different operating characteristics and may perform better or worse
depending on the setting.
2.6.1 Inferential procedure
The inferential procedure for the synthetic control estimator, detailed in Section 2.3.1, can
again be used here for exact inference.
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2.6.2 Computation
This procedure is implemented in the R code available at:
https://github.com/leekshaffer/SW-CRT-analysis.
Other ensemble methods can be constructed by altering the weights and estimators used; a
generic function is provided for this purpose in the R code.
3 Results
We compare the performance of these novel methods with the existing methods under two
simulation settings: the first using the risk difference contrast, g(y1, y2) = y1 − y2, and the
second using the log odds ratio contrast, g(y1, y2) = log
(
y1/(1−y1)
y2/(1−y2)
)
. As SW-CRTs most
commonly have binary outcomes, we consider binary outcomes here; the methods, however,
also work for continuous outcomes. Throughout we denote the methods considered as follows:
• MEM denotes the mixed-effects model defined in equation (1).
• CPI denotes the mixed-effects model with a cluster-period random effect defined in
equation (2).
• NPWP denotes the non-parametric within-period method defined in equations (3) and
(4).
• SC-1 denotes the synthetic control method defined in equations (6) and (7), with equal
weights across cluster-period estimators.
• SC-2 denotes the synthetic control method with inverse-MSPE weights as defined in
equation (8). In this case, there is only one cluster crossing over per period, so the
estimators are weighted by inverse-MSPE within each target cluster, and then equally
weighted across clusters.
• CO-1 denotes the crossover method defined in equations (10) and (12), using compar-
ison data only from control clusters, with equal weights.
• CO-2 denotes the crossover method defined in equations (10) and (12), using compar-
ison data only from control clusters, with weights proportional to the harmonic mean
of the number of control and crossover clusters.
• CO-3 denotes the crossover method defined in equations (11) and (12), using compar-
ison data from both control clusters and intervention clusters, with equal weights.
• COSC-1 denotes the crossover-synthetic control method defined in equations (13) and
(14) with equal weights across cluster-specific estimators.
• COSC-2 denotes the crossover-synthetic control method with inverse-MSPE weights
defined in equation (15).
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• ENS denotes the ensemble method defined in equation (16), using a simple mean of
SC-2 and CO-2.
All inference is based on exact permutation tests, except for asymptotic inference using the
MEM and CPI models, which is denoted by MEM-a and CPI-a. All permutation tests were
conducted with 500 randomly-sampled permutations of the crossover order.
3.1 Simulation 1: risk difference
3.1.1 Setting and parameters
We consider a setting where the risk difference is the contrast of interest. There are I = 7
clusters and J = 8 time periods, with one cluster beginning treatment in each of periods 2
through 8. At each cluster-period, K = 100 individuals are sampled. The data are generated
from a mixed effects model similar to that in equation (2) with µ = 0.30 and τ = 0.06, with
an identity link. We consider four scenarios:
1. Fixed time effects θ = θ1 ≡ (0, 0.08, 0.18, 0.29, 0.30, 0.27, 0.20, 0.13) and no cluster-
period effect (ν = 0). The MEM model is correctly specified in this case.
2. Fixed time effects θ = θ1 and cluster-period effect with ν = 0.01. The CPI model is
correctly specified in this case.
3. Equal probability of each cluster having either the time effects θ1 or
θ2 ≡ (0, 0.02, 0.03, 0.07, 0.13, 0.19, 0.27, 0.3). No cluster-period effect (ν = 0). Neither
MEM nor CPI is correctly specified in this case.
4. Equal probability of each cluster having either the time effects θ1 or θ2. Cluster-period
effect with ν = 0.01. Neither MEM nor CPI is correctly specified in this case.
Note that all scenarios satisfy the conditions of Corollaries 1 and 2 and Theorem 3 in Ap-
pendix A, so the SC-1 estimator is asymptotically unbiased and the CO estimators are
unbiased. Since SC-2 does not have equal weights, it does not meet the conditions of Theo-
rem 2 or Corollary 2, so we cannot guarantee it is asymptotically unbiased. For scenarios 1
and 2, the global mean vector is Y·J = µ+θ1. For scenarios 3 and 4, the global mean vector
is Y·J = µ+
θ1+θ2
2
.
For each scenario, 1,000 data sets were simulated for each of three treatment effects:
β = −0.2, β = −0.1, and β = 0. We do not present the results for the strong treatment
effect (β = −0.2) here, as they are very similar to those for the moderate treatment effect
(β = −0.1), but with such high power (all methods except NPWP over 90% in all scenarios)
that it is hard to distinguish differences. A representative plot of cluster outcomes for each
of the four scenarios with no treatment effect is given in Figure 2. If the probability of
outcome for any cluster-period was less than 0 or greater than 1, it was truncated to 0 or 1,
respectively. Code to generate and analyze the simulated data is available at:
https://github.com/leekshaffer/SW-CRT-analysis.
For each of the twelve scenarios, each data set was analyzed using the following methods:
MEM, CPI, NPWP, SC-1, SC-2, CO-1, CO-2, CO-3, COSC, and ENS. Note that since only
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one cluster crosses over in each period, COSC-2 is equivalent to COSC-1; this is denoted
COSC. The weights for SC-2 are calculated with inverse-MSPE weighting only within each
intervention cluster but still differ from SC-1, which is equally weighted among all cluster-
periods.
3.1.2 Simulation results
Figure 3 shows the mean effect estimate and 1/2-standard deviation of the effect estimates
across the 1,000 simulations for each method for each scenario. The two subplots each
show the scenarios for one treatment effect, with Scenario 1 at the top and Scenario 4 at
the bottom of each plot. For all of the settings, all of the methods exhibit little overall
bias, with the average estimate for each method within 0.005 of the true effect in each
scenario. As expected given that all four scenarios meet the assumptions of Corollary 2
and Theorem 3, SC-1, CO-1, and CO-2 appear to be unbiased in the simulations. As
noted by Thompson et al.,38 the nonparametric estimator NPWP must also be unbiased
in all scenarios. Despite the misspecification of MEM and CPI in scenarios 3 and 4, they
nonetheless result in unbiased estimators, albeit with wider empirical variance. And SC-
2 appears unbiased in these simulations as well, despite its not meeting the conditions of
Corollary 2. The variability of the effect estimates varies a great deal by method, with the
MEM and CPI methods exhibiting the least variability when the time effects do not vary,
and the CO and ENS methods exhibiting the least variability when the time effects do vary.
Figure 4 shows the Type I Error (probability of finding a significant treatment effect when
β = 0) for each analysis method under each scenario. All of the methods are close to the
nominal Type I Error of 5% with the exception of asymptotic inference for the MEM and
CPI methods when the time effects vary. All of the exact inference methods also achieve the
nominal coverage in 95% confidence intervals, as shown in Figure 5. When the time effects
do not vary, the MEM and CPI methods with asymptotic inference also achieve or nearly
achieve the nominal coverage; when the time effects do vary, they both have less than 90%
coverage.
Figure 6 shows the power (estimated probability of finding a significant treatment effect
at the 5% significance level) for each analysis method under each scenario for the moderate
treatment effect (β = −0.1). The asymptotic inference MEM and CPI results are not shown
when the time effects vary as they have inflated Type I Error. The MEM and CPI (exact
or asymptotic inference) methods have the highest power when the time effects do not vary.
When the time effects do vary, the CO and ENS methods perform the best among the
exact inference methods, followed by the COSC, SC, MEM, and CPI methods. The NPWP
method has the least power. As expected with weights selected to reduce variance, CO-2
outperforms CO-1 and SC-2 outperforms SC-1. These differences, however, are smaller than
the differences between classes of methods.
3.2 Simulation 2: odds ratio
3.2.1 Setting and parameters
We consider now a setting where the odds ratio is the contrast of interest. There are again
I = 7 clusters and J = 8 time periods, with one cluster beginning treatment in each of
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periods 2 through 8. At each cluster-period, K = 100 individuals are sampled. The data are
generated from a mixed effects model similar to that in equation (2) with µ = logit(0.30)
and τ = 0.1, with a logit link. We consider four scenarios:
1. Fixed time effects θ = θ1 ≡ log(1, 1.43, 2.15, 3.36, 3.50, 3.09, 2.33, 1.76) and no cluster-
period effect (ν = 0). The MEM model is correctly specified in this case.
2. Fixed time effects θ = θ1 and cluster-period effect with ν = 0.01. The CPI model is
correctly specified in this case.
3. Equal probability of each cluster having either the time effects θ1 or
θ2 ≡ log(1, 1.10, 1.15, 1.37, 1.76, 2.24, 3.09, 3.50). No cluster-period effect (ν = 0). Nei-
ther MEM nor CPI is correctly specified in this case.
4. Equal probability of each cluster having either the time effects θ1 or θ2. Cluster-period
effect with ν = 0.01. Neither MEM nor CPI is correctly specified in this case.
For each scenario, 1,000 data sets were simulated for each of three treatment effects: β =
log(0.50) ≈ −0.693, β = log(0.66) ≈ −0.416, and β = log(1) = 0. We do not present
the results for the strong treatment effect (β = log(0.50) ≈ −0.693) here, as they are very
similar to those for the moderate treatment effect (β = log(0.66) ≈ −0.416), but with such
high power (all methods over 90% in all scenarios) as to make comparisons difficult. These
parameters were chosen to give similar outcome probabilities under control as in Simulation
1, but specified on the log-odds ratio scale. A representative plot of cluster outcomes for
each of the four scenarios with no treatment effect is given in Figure 7. Code to generate
and analyze the simulated data is available at:
https://github.com/leekshaffer/SW-CRT-analysis.
For each of the twelve scenarios, each data set was analyzed using the same set of methods
as in the previous section.
3.2.2 Simulation results
Figure 8 shows the mean effect estimate and 1/2-standard deviation of the effect estimates
across the 1,000 simulations for each method for each scenario. The three subplots each
show the scenarios for one treatment effect, with Scenario 1 at the top and Scenario 4 at
the bottom of each plot. For all of the settings, all of the methods exhibit little overall bias,
with the average estimate for each method within 0.01 of the true effect in each scenario.
The variability of the effect estimates varies a great deal by method, however, with MEM
and CPI methods exhibiting the least variability when the time effects do not vary, and the
CO, SC, and ENS methods exhibiting the least variability when the time effects do vary.
Figure 9 shows the Type I Error (probability of finding a significant treatment effect when
β = 0) for each analysis method under each scenario. All of the methods are close to the
nominal Type I Error of 5% with the exception of asymptotic inference for the MEM and
CPI methods when the time effects vary. All of the exact inference methods also achieve the
nominal coverage in 95% confidence intervals, as shown in Figure 10. When the time effects
do not vary, the MEM and CPI methods with asymptotic inference also achieve or nearly
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achieve the nominal coverage; when the time effects do vary, they both have less than 90%
coverage.
Figure 11 shows the power for each analysis method under each scenario for the moderate
treatment effect (β = log(0.66) ≈ −0.416). The asymptotic inference MEM and CPI results
are not shown when the time effects vary as they have inflated Type I Error. The MEM and
CPI (exact or asymptotic inference) methods have the highest power when the time effects
do not vary, but there is relatively little loss of power for the ENS, SC, and CO-3 methods.
When the time effects do vary, the ENS method performs the best among the exact inference
methods, followed by the CO-3 method, the SC and other CO methods, and then the COSC
method. The NPWP and exact inference MEM and CPI methods have the least power.
These results are largely similar to those seen in Simulation 1. This suggests that the
contrast of interest is less important to the relative performance of these methods than the
underlying distribution of the data.
3.3 Variance and covariance of estimators
To assess the variability between methods for a given instance of analysis, we determined the
pairwise covariance for each pair of methods across the simulated settings. Within each data-
generating setting, we found the covariance between methods across all 1,000 simulations.
As a representative example of these covariances, we take scenario 4, the scenario with the
most complex data-generating process, under the null hypothesis of no treatment effect, for
both Simulation 1 and Simulation 2. The covariances are displayed in the heat map shown in
Figure 12 for the risk difference (Simulation 1) and in Figure 13 for the odds ratio (Simulation
2). Note that the empirical variances for each method across the 1,000 simulations are on
the diagonal of the figure.
These results indicate rather high correlations within classes of methods; that is, the
mixed effects model methods are highly correlated with one another, the synthetic con-
trol methods are highly correlated with one another, and the crossover methods (including
COSC) are highly correlated with one another. NPWP is correlated with the mixed effects
model methods and the SC methods; it has high covariance with these methods largely
because of its high variance.
The least covariance occurs between any mixed effects or vertical (NPWP or SC) method
and any of the CO-based methods. This suggests that using an ensemble method combining
an SC method and a CO method is indeed valuable here, as, for example, the covariance
of SC-2 and CO-2 is notably smaller than the variance of SC-2 and the variance of CO-2.
This corresponds with the increased power for the ENS method compared with SC-2 and
CO-2 seen in the previous sections. The relatively low, equal covariance of ENS with the
other methods suggests there is little to be gained in this setting by more complex ensemble
methods.
3.4 Application to tuberculosis SW-CRT
We applied the methods discussed here to a SW-CRT that assessed the effect of a tuber-
culosis (TB) diagnostic test on reducing unsuccessful (non-cure) outcomes of adults on TB
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treatment.43 Note that this is the same trial re-analyzed by Thompson et al. using the
within-period methods they proposed.38
3.4.1 Trial description
In this study, Trajman et al. conducted a SW-CRT in fourteen laboratories in the Brazilian
cities of Rio de Janeiro and Manaus. While in the control arm, the labs diagnosed TB
using two-sample sputum smear microscopy; in the intervention arm, diagnosis and first-line
evaluation of potential drug resistance was by a single sputum sample XpertMTB/RIF assay.
Data were collected on individuals diagnosed with TB in eight months in 2012 in the clinics
associated with these laboratories. In the first month, all labs were in the control arm. In
each subsequent month, two labs were switched to the intervention arm. In the final month,
all labs were in the intervention arm.53
The outcome of interest was the proportion of unfavorable TB treatment outcomes,
where unfavorable outcomes are defined as: loss to follow-up, TB-attributed death, death
from other causes, change of diagnosis, transfer out (including to specialized clinics for
management of drug-resistant TB or drug intolerance), and suspicion of drug resistance. In
total, the trial analyzed the intervention and outcome status of 4,054 patients.43
3.4.2 Goodness of fit of mixed effects models
Before analyzing these data using non-parametric approaches, we consider the goodness of
fit of the mixed effects models. We fit both the MEM and CPI models, as usual assuming
independent normally-distributed random effects. In this case, the CPI model yields nearly
the same fitted values as the MEM model, so we consider only the MEM model from this
point. A variety of methods have been proposed to assess the assumption of independent
normally-distributed random effects.54–60 We use several of these methods to assess the
assumption in this case; details are in Appendix C. Some methods indicate a violation of the
assumption and others do not, but caution should be exercised in interpreting these results
as diagnostic tests may not be powerful or reliable for such a small number of clusters.61
Because of the potential of model misspecification, we proceed with the non-parametric
analyses.
3.4.3 Results
The primary analysis conducted by Trajman et al., which did not adjust for time effects,
found a decrease in the number of events (unsuccessful outcomes) in the intervention arm
compared to the control arm, although this decrease was not statistically significant at the
0.05 level.43 Re-analyzing the data using the NPWP method, Thompson et al. found a
statistically significant decrease on both the odds ratio and risk difference scales.38
We analyzed these data using all of the methods described here using both the risk
difference and log odds ratio contrasts; all exact inference methods use 500 permutations.
Note that the NPWP method corresponds to that used by Thompson et al. for the risk
difference scale. For the odds ratio, we use the log odds ratio contrast and exponentiate
after averaging across periods for comparability with the SC and CO methods, whereas
Thompson et al. calculate on the odds ratio scale directly, leading to a slight difference in
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the estimate.38 In both cases, inference may differ slightly because of the stochasticity in
the permutation-based inference. This stochasticity, as well as the difference of calculating
under the alternative hypothesis rather than the null, can also lead to confidence intervals
including the null when the hypothesis test rejects the null and vice versa. Also note that
since there are two clusters which cross over at each time period, COSC-1 and COSC-2 yield
different results. The results, reported on the risk difference scale and the odds ratio scale,
are summarized in Table 1.
Table 1: Results from SW-CRT of diagnostic method on rates of unfavorable TB treatment
outcomes in Brazil, by analysis method
Risk Difference Odds Ratio
Method Estimate 95% Conf. Int. p Estimate 95% Conf. Int. p
MEM/CPI -3.59% (-8.9%, 1.4%) 0.126 0.835 (0.66, 1.07) 0.104
MEM/CPI-a -3.59% (-8.4%, 1.1%) 0.105 0.835 (0.66, 1.05) 0.091
NPWP -4.83% (-10.1%, 0.1%) 0.050 0.794 (0.61, 0.99) 0.046
SC-1 -7.28% (-18.2%, 1.0%) 0.084 0.703 (0.44, 1.04) 0.066
SC-2 -8.29% (-18.3%, 1.1%) 0.080 0.675 (0.43, 1.07) 0.082
CO-1 -7.34% (-14.5%, 0.5%) 0.064 0.703 (0.49, 1.04) 0.046
CO-2 -6.97% (-14.0%, 0.5%) 0.052 0.717 (0.50, 1.03) 0.054
CO-3 -7.00% (-14.0%, 0.0%) 0.050 0.721 (0.51, 1.00) 0.036
COSC-1 -7.01% (-15.5%, 1.1%) 0.078 0.728 (0.49, 1.10) 0.118
COSC-2 -5.12% (-14.7%, 4.5%) 0.242 0.784 (0.50, 1.18) 0.222
ENS -7.63% (-15.0%, -0.6%) 0.036 0.696 (0.49, 0.95) 0.032
The novel methods identify a stronger treatment effect than do the model-based and
NPWP methods. As Thompson et al. show, the NPWP method here places a large amount
of weight on the contrast in the fifth period, which has a modest (-2.23%) effect.24 This
attenuates the effect compared to, for example, CO-1, which equally weights contrasts in
different periods. It also, however, reduces the variance of the overall estimator, thus yielding
a lower p-value for the NPWP method than the CO methods which use the control crossovers
only. The COSC methods do not appear to give more precision than the CO methods, but
yield similar effect estimates. On both scales, the ENS method yields the lowest p-values,
as it detects a strong effect and has more precision than the other novel methods. All of
the results suggest a protective effect of the intervention, with the novel methods detecting
a larger effect but with more uncertainty, and the NPWP method estimating a narrower
confidence interval of smaller effect sizes. In this example, inference does indeed depend
upon the analysis method used, demonstrating the need for consideration of the assumptions
underlying each method.
4 Discussion
These results demonstrate the potential of analytic methods for SW-CRTs that do not rely
on parametric modeling of secular trends for validity. These methods achieve greater power
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than the purely vertical within-period method by using the history of outcomes within each
cluster inherently collected in a SW-CRT to match the most similar clusters or by using
horizontal, within-cluster information. In the simulation settings used here, when the mixed
effects models were misspecified, an ensemble method that averaged the crossover method
and the synthetic control method had the highest power to detect a true treatment effect,
followed by the crossover method. Further research is needed to determine in which settings
each of these methods is likely to perform the best, and whether an ensemble method can
be constructed to be powerful across settings. These results demonstrate that this simple
ensemble method may in some settings perform better, but not that it always will or that
this is the most powerful ensemble method for any particular setting. The potential for
incorporating measured covariates or stratified randomization into the SC method may also
lead to increased power in some situations.
While these methods are valuable and in general rely on weaker assumptions than mixed
effects methods do for unbiasedness, they are still not as powerful as parametric mixed effects
methods when the modeling assumptions are met. This leaves an important role for investi-
gators to determine when assumptions are likely to be met and for research on secular trends
in the conditions and interventions commonly studied by SW-CRTs to determine when non-
parametric methods are needed. Additionally, further work on using regression diagnostics
to identify violations of modeling assumptions would be very valuable. Investigators should
consider exact inference on parametric methods when the modeling assumptions of mixed
effects methods are likely to nearly hold and the non-parametric methods when the secular
trends are unknown or the modeling assumptions methods are likely to be strongly violated.
Caution should be exercised regarding the SC methods as well when the underlying data
distribution is unlikely to be symmetric or asymptotically symmetric.
As can be seen in the imperfect correlation across methods and the variability of the
estimates, with relatively few clusters, the estimation can be very sensitive to the analysis
method, and even the weighting scheme, chosen. The performance of any method in one
particular analysis of a trial may not reflect its overall operating characteristics. The specific
settings where the estimators depend heavily on certain cluster-periods and the impact
that has on operating characteristics deserve more scrutiny. Again, this is an area where
ensemble methods may prove useful in mitigating high dependence on specific cluster-periods
by certain methods.
The methods presented here also provide advantages in interpretability and flexibility.
When the treatment effect is not constant across clusters or across time periods, the mixed
effects model estimate for nonlinear link functions is a conditional parameter, and its in-
terpretation can be unclear.62 For linear link functions, the mixed effects model estimate
is a weighted average intervention effect that depends on the form of the time trend in the
treatment effect.23 With the non-parametric methods, using equal weighting across clusters
and periods, the estimate is easily interpreted as an average treatment effect across cluster-
periods in the study. Other causal effects can be estimated using weights chosen to match the
target parameter, depending on the effect of interest and assumptions the investigators are
willing to make about generalizability to a separate target population. More work is needed
to determine how to select weights that maximize efficiency for specific causal parameters
that may be of common interest. For instance, if the effect of time on the intervention ef-
fect is known or a parametric form can be assumed, there may be an efficiency-maximizing
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weighting scheme.
When treatment effects are not instantaneous—common in settings where treatment
effects vary over time—methods must be modified. Throughout this article, we have assumed
that the full effect of treatment occurs during the first period of treatment and that there
are no anticipation effects prior to that point. In practice, it may be desirable to account
for a lag in, or gradual onset of, treatment effects resulting from logistical complexity in
reaching everyone in the cluster or for the effect to reach its full strength.8,13 This can be
incorporated into the SC methods by taking as the time of start of the intervention the time
of completion of such a transition period. It can be incorporated into the CO methods by
taking as the “crossover effect” the contrast between the first period after the transition and
the last period prior to any anticipation effects. Achieving the same efficiency as would be
achieved with a similar trial with no transition period may require more clusters or more
time between successive cluster crossovers. All SW-CRT methods are sensitive to properly
accounting for the transition period, but the CO methods are particularly sensitive because
of their focus on the horizontal comparison. If the transition period length is unknown or
likely to vary across clusters, the CO methods may not be appropriate.
The synthetic control method allows for additional flexibility and the potential for in-
creased power and use in a wider variety of settings. As mentioned above, it can be useful
when lagged treatment effects or time-varying treatment effects make a specific causal es-
timand more desirable as a target for inference. It also, as shown in the simulations here,
can be a valuable part of an ensemble method that improves the power of an estimator.
And for trials with more periods, or a longer pre-intervention history, the SC method itself
may perform better. In general, it provides many of the advantages of the non-parametric
within-period method while using a matching-like procedure to increase power. For the
COSC method, the relatively poor performance in these simulation settings may stem from
the fact that one period of history is lost by using the crossover estimator. With few peri-
ods, that can have a large effect on the power. Again, a longer pre-intervention history may
improve the value of this method.
Additionally, more advanced techniques can be used to improve synthetic control match-
ing and thus potentially improve the power of the SC and COSC methods. Synthetic controls
can incorporate measured covariates to improve the matching.41,63 Moreover, new synthetic
control algorithms and methodologies may also be useful in improving the matching and de-
signing efficiency-maximizing weighting schemes. These include Bayesian synthetic control
approaches,64,65 flexible non-parametric synthetic control,66 generalized synthetic control,67
and augmented synthetic control.68 The SC method, potentially incorporating these ap-
proaches to improve the causal inference component, may also provide a path for analysis of
non-randomized studies that mimic stepped wedge trials, as the synthetic control may ad-
dress confounding of treatment initiation. Further work is needed in this area to determine
whether the stepped wedge trial design can be used as a target trial for causal inference from
observational studies.69,70
These methods increase the number of analysis options available to investigators conduct-
ing stepped wedge cluster randomized trials. The SC method provides a semi-parametric
option that relies on weaker assumptions on the underlying data-generating process than
mixed effects models, while increasing power compared to the NPWP method, and it can be
improved with advanced methods or with additional pre-intervention data. The CO method
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provides a non-parametric option with greatly improved power, although it relies on a con-
stant treatment effect that appears very soon after treatment initiation. Variations of these
methods and ensemble methods can also be used to target specific causal parameters and
improve power in certain circumstances. Careful consideration is still required, however,
to determine which analysis method is most appropriate for each individual circumstance,
and more work is needed to clarify how to make that determination a priori or in a sys-
tematic way. Moreover, careful selection of analysis method does not alleviate all of the
drawbacks and concerns about SW-CRTs and, as mentioned above, does not ensure ideal
performance of any single analysis. Investigators should continue to select the appropriate
trial design for each study, taking into account analysis methods, the target estimand, and
power considerations, along with issues of logistical feasibility, ethics, risk-benefit profiles,
and generalizability.
Financial disclosure
Research reported in this publication was supported by the National Institute of Allergy
and Infectious Diseases under Award Numbers 5T32AI007358-28 and 1F31AI147745 (for
L.K.S.), and R3751164 (for V.d.G.); and National Institute of General Medical Sciences
Award Number U54GM088558 (for M.L.).
Conflict of interest
The authors declare no potential conflicts of interest.
Code Availability
R code to implement the methods detailed in this article is available at:
https://github.com/leekshaffer/SW-CRT-analysis.
The code is still in progress as we work to improve usability and speed of implementation.
Additionally, code to replicate the simulations detailed here and to generate the figures from
those simulations is available at the same source.
References
[1] Halloran ME, Longini IM, Struchiner CJ. Design and Analysis of Vaccine Studies.
Statistics for Biology and Health. New York: Springer; 2010.
[2] Eldridge S, Kerry S. A Practical Guide to Cluster Randomised Trials in Health Services
Research. Statistics in Practice. Chichester, UK: John Wiley & Sons; 2012.
[3] Hayes RJ, Moulton LH. Cluster Randomised Trials. 2nd ed. Chapman & Hall/CRC
Interdisciplinary Statistics Series. Boca Raton, FL: CRC Press; 2017.
[4] Kahn R, Rid A, Smith PG, Eyal N, Lipsitch M. Choices in vaccine trial design in
epidemics of emerging infections. PLoS Med. 2018; 15(8): e1002632.
21
[5] Hitchings MDT, Lipsitch M, Wang R, Bellan SE. Competing Effects of Indirect Pro-
tection and Clustering on the Power of Cluster-Randomized Controlled Vaccine Trials.
Am. J. Epidemiol. 2018; 187(8): 1763–1771.
[6] Bellan SE, Eggo RM, Gsell PS, et al. An online decision tree for vaccine efficacy trial
design during infectious disease epidemics: The InterVax-Tool. Vaccine 2019; 37(31):
4376–4381.
[7] Brown CA, Lilford RJ. The stepped wedge trial design: a systematic review. BMC Med.
Res. Methodol. 2006; 6(1): 54.
[8] Hemming K, Haines TP, Chilton PJ, Girling AJ, Lilford RJ. The stepped wedge cluster
randomised trial: rationale, design, analysis, and reporting. BMJ 2015; 350: h391.
[9] Beard E, Lewis JJ, Copas A, et al. Stepped wedge randomised controlled trials: sys-
tematic review of studies published between 2010 and 2014. Trials 2015; 16: 353.
[10] Davey C, Hargreaves J, Thompson JA, et al. Analysis and reporting of stepped wedge
randomised controlled trials: synthesis and critical appraisal of published studies, 2010
to 2014. Trials 2015; 16: 358.
[11] Barker D, McElduff P, D’Este C, Campbell MJ. Stepped wedge cluster randomised
trials: a review of the statistical methodology used and available. BMC Med. Res.
Methodol. 2016; 16(1): 69.
[12] Hussey MA, Hughes JP. Design and analysis of stepped wedge cluster randomized trials.
Contemp. Clin. Trials 2007; 28(2): 182–191.
[13] Copas AJ, Lewis JJ, Thompson JA, Davey C, Baio G, Hargreaves JR. Designing a
stepped wedge trial: three main designs, carry-over effects and randomisation ap-
proaches. Trials 2015; 16: 352.
[14] Prost A, Binik A, Abubakar I, et al. Logistic, ethical, and political dimensions of stepped
wedge trials: critical review and case studies. Trials 2015; 16: 351.
[15] Tugwell P, Knottnerus JA. Stepped wedge designs are coming of age in clinical epidemi-
ology. J. Clin. Epidemiol. 2019; 107: vi–viii.
[16] Mdege ND, Man MS, Taylor CA, Torgerson DJ. Systematic review of stepped wedge
cluster randomized trials shows that design is particularly used to evaluate interventions
during routine implementation. J. Clin. Epidemiol. 2011; 64(9): 936–948.
[17] Keriel-Gascou M, Buchet-Poyau K, Rabilloud M, Duclos A, Colin C. A stepped wedge
cluster randomized trial is preferable for assessing complex health interventions. J. Clin.
Epidemiol. 2014; 67(7): 831–833.
[18] Kotz D, Spigt M, Arts ICW, Crutzen R, Viechtbauer W. Use of the stepped wedge
design cannot be recommended: a critical appraisal and comparison with the classic
cluster randomized controlled trial design. J. Clin. Epidemiol. 2012; 65(12): 1249–1252.
22
[19] Hargreaves JR, Copas AJ, Beard E, et al. Five questions to consider before conducting
a stepped wedge trial. Trials 2015; 16: 350.
[20] Eyal N, Lipsitch M. Vaccine testing for emerging infections: the case for individual
randomisation. J. Med. Ethics 2017; 43(9): 625–631.
[21] Mdege ND, Kanaan M. Response to Keriel-Gascou et al. Addressing assumptions on
the stepped wedge randomized trial design. J. Clin. Epidemiol. 2014; 67(7): 833–834.
[22] Viechtbauer W, Kotz D, Spigt M, Arts ICW, Crutzen R. Response to Keriel-Gascou
et al.: higher efficiency and other alleged advantages are not inherent to the stepped
wedge design. J. Clin. Epidemiol. 2014; 67(7): 834–836.
[23] Nickless A, Voysey M, Geddes J, Yu LM, Fanshawe TR. Mixed effects approach to the
analysis of the stepped wedge cluster randomised trial—Investigating the confounding
effect of time through simulation. PLoS One 2018; 13(12): e0208876.
[24] Thompson JA, Fielding KL, Davey C, Aiken AM, Hargreaves JR, Hayes RJ. Bias and
inference from misspecified mixed-effect models in stepped wedge trial analysis. Stat.
Med. 2017; 36(23): 3670–3682.
[25] Hooper R, Teerenstra S, Hoop dE, Eldridge S. Sample size calculation for stepped wedge
and other longitudinal cluster randomised trials. Stat. Med. 2016; 35(26): 4718–4728.
[26] Hartford A, Davidian M. Consequences of misspecifying assumptions in nonlinear mixed
effects models. Comput. Stat. Data Anal. 2000; 34(2): 139–164.
[27] Heagerty PJ, Kurland BF. Misspecified maximum likelihood estimates and generalised
linear mixed models. Biometrika 2001; 88(4): 973–985.
[28] Agresti A, Caffo B, Ohman-Strickland P. Examples in which misspecification of a ran-
dom effects distribution reduces efficiency, and possible remedies. Comput. Stat. Data
Anal. 2004; 47(3): 639–653.
[29] Litie`re S, Alonso A, Molenberghs G. Type I and type II error under random-effects
misspecification in generalized linear mixed models. Biometrics 2007; 63(4): 1038–1044.
[30] Litie`re S, Alonso A, Molenberghs G. The impact of a misspecified random-effects distri-
bution on the estimation and the performance of inferential procedures in generalized
linear mixed models. Stat. Med. 2008; 27(16): 3125–3144.
[31] McCulloch CE, Neuhaus JM. Prediction of random effects in linear and generalized
linear models under model misspecification. Biometrics 2011; 67(1): 270–279.
[32] Wang R, De Gruttola V. The use of permutation tests for the analysis of parallel and
stepped-wedge cluster-randomized trials. Stat. Med. 2017; 36(18): 2831–2843.
[33] Ji X, Fink G, Robyn PJ, Small DS. Randomization inference for stepped-wedge cluster-
randomized trials: an application to community-based health insurance. Ann. Appl.
Stat. 2017; 11(1): 1–20.
23
[34] Davidian M, Gallant AR. The Nonlinear Mixed Effects Model with a Smooth Random
Effects Density. Biometrika 1993; 80(3): 475–488.
[35] Zhang D, Davidian M. Linear mixed models with flexible distributions of random effects
for longitudinal data. Biometrics 2001; 57(3): 795–802.
[36] Chen J, Zhang D, Davidian M. A Monte Carlo EM algorithm for generalized linear
mixed models with flexible random effects distribution. Biostatistics 2002; 3(3): 347–
360.
[37] Scott JM, deCamp A, Juraska M, Fay MP, Gilbert PB. Finite-sample corrected gen-
eralized estimating equation of population average treatment effects in stepped wedge
cluster randomized trials. Stat. Methods Med. Res. 2017; 26(2): 583–597.
[38] Thompson JA, Davey C, Fielding K, Hargreaves JR, Hayes RJ. Robust analysis of
stepped wedge trials using cluster-level summaries within periods. Stat. Med. 2018;
37(16): 2487–2500.
[39] Hughes JP, Heagerty PJ, Xia F, Ren Y. Robust Inference for the Stepped Wedge Design.
Biometrics 2019.
[40] Abadie A, Gardeazabal J. The economic costs of conflict: a case study of the Basque
Country. Am. Econ. Rev. 2003; 93(1): 113–132.
[41] Abadie A, Diamond A, Hainmueller J. Synthetic control methods for comparative case
studies: estimating the effect of California’s tobacco control program. J. Am. Stat.
Assoc. 2010; 105(490): 493–505.
[42] Abadie A, Diamond A, Hainmueller J. Comparative Politics and the Synthetic Control
Method. Am. J. Pol. Sci. 2015; 59(2): 495–510.
[43] Trajman A, Durovni B, Saraceni V, et al. Impact on patients’ treatment outcomes
of XpertMTB/RIF implementation for the diagnosis of tuberculosis: follow-up of a
stepped-wedge randomized clinical trial. PLoS One 2015; 10(4): e0123252.
[44] Gautier PA, Siegmann A, Van Vuuren A. Terrorism and attitudes towards minorities:
the effect of the Theo van Gogh murder on house prices in Amsterdam. J. Urban Econ.
2009; 65(2): 113–126.
[45] Abadie A, Diamond A, Hainmueller J. Synth: an R package for synthetic control meth-
ods in comparative case studies. Journal of Statistical Software 2011; 42(13): 1–17.
[46] Dube A, Zipperer B. Pooling multiple case studies using synthetic controls: an appli-
cation to minimum wage policies. Tech. Rep. 8944, Institution for the Study of Labor;
2015.
[47] Donohue JJ, Aneja A, Weber KD. Right-to-carry laws and violent crime: a comprehen-
sive assessment using panel data and a state-level synthetic control analysis. Tech. Rep.
23510, National Bureau of Economic Research; 2018.
24
[48] Powell D. Synthetic control estimation beyond case studies: does the minimum wage
reduce employment?. Tech. Rep. WR-1142, RAND Labor & Population; 2017.
[49] Everitt BS. The analysis of repeated measures: a practical review with examples. J. R.
Stat. Soc. Ser. D The Statistician 1995; 44(1): 113–135.
[50] Jones B, Donev AN. Modelling and design of cross-over trials. Stat. Med. 1996; 15(13):
1435–1446.
[51] Omar RZ, Wright EM, Turner RM, Thompson SG. Analysing repeated measurements
data: a practical comparison of methods. Stat. Med. 1999; 18(13): 1587–1603.
[52] Fitzmaurice GM. Applied longitudinal analysis. 2nd ed. Wiley series in probability and
statistics. Hoboken, N.J.: Wiley; 2011.
[53] Durovni B, Saraceni V, Hof v. dS, et al. Impact of replacing smear microscopy
with XpertMTB/RIF for diagnosing tuberculosis in Brazil: a stepped-wedge cluster-
randomized trial. PLoS Med. 2014; 11(12): e1001766.
[54] Alonso A, Litie`re S, Molenberghs G. A family of tests to detect misspecifications in the
random-effects structure of generalized linear mixed models. Comput. Stat. Data Anal.
2008; 52(9): 4474–4486.
[55] Huang X. Diagnosis of random-effect model misspecification in generalized linear mixed
models for binary response. Biometrics 2009; 65(2): 361–368.
[56] Verbeke G, Molenberghs G. The gradient function as an exploratory goodness-of-fit
assessment of the random-effects distribution in mixed models. Biostatistics 2013; 14(3):
477–490.
[57] Meintanis SG, Allison JS, Santana L. Diagnostic tests for the distribution of random
effects in multivariate mixed effects models. Commun. Stat. Theory Methods 2016; 45(1):
201–215.
[58] Drikvandi R. Nonlinear mixed-effects models for pharmacokinetic data analysis: assess-
ment of the random-effects distribution. J. Pharmacokinet. Pharmacodyn. 2017; 44(3):
223–232.
[59] Singer JM, Nobre JS, Rocha FMM. Diagnostic and treatment for linear mixed models.
In: Proceedings of the 59th ISI World Statistics Congress, August; 2013: 25–30.
[60] Ritz C. Goodness-of-fit tests for mixed models. Scand. Stat. Theory Appl. 2004; 31(3):
443–458.
[61] Yap BW, Sim CH. Comparisons of various types of normality tests. J. Stat. Comput.
Simul. 2011; 81(12): 2141–2155.
[62] Hubbard AE, Ahern J, Fleischer NL, et al. To GEE or not to GEE: comparing popu-
lation average and mixed models for estimating the associations between neighborhood
risk factors and health. Epidemiology 2010; 21(4): 467–474.
25
[63] Botosaru I, Ferman B. On the role of covariates in the synthetic control method.
Econom. J. 2019; 22.
[64] Bruhn CAW, Hetterich S, Schuck-Paim C, et al. Estimating the population-level impact
of vaccines using synthetic controls. Proc. Natl. Acad. Sci. U. S. A. 2017; 114(7): 1524–
1529.
[65] Kim S, Lee C, Gupta S. Bayesian synthetic control methods. Tech. Rep. 3382359, SSRN;
2019.
[66] Cerulli G. A flexible synthetic control method for modeling policy evaluation. Econ.
Lett. 2019; 182: 40–44.
[67] Xu Y. Generalized synthetic control method: causal inference with interactive fixed
effects models. Polit. Anal. 2017; 25(1): 57–76.
[68] Ben-Michael E, Feller A, Rothstein J. The augmented synthetic control method.
arXiv:1811.04170 [stat.ME] 2018.
[69] Herna´n MA, Sauer BC, Herna´ndez-Dı´az S, Platt R, Shrier I. Specifying a target trial
prevents immortal time bias and other self-inflicted injuries in observational analyses.
J. Clin. Epidemiol. 2016; 79: 70–75.
[70] Garc´ıa-Albe´niz X, Hsu J, Herna´n MA. The value of explicitly emulating a target trial
when using real world evidence: an application to colorectal cancer screening. Eur. J.
Epidemiol. 2017; 32(6): 495–500.
26
Figures
(a) Non−Parametric Within−Period Analysis Method
for SW−CRT. The Estimator for Period 4 is the
Unweighted Mean of the Outcomes in the Upper
Highlighted Box Compared to the Unweighted Mean
of the Outcomes in the Lower Highlighted Box.
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(b) Synthetic Control Analysis Method for SW−CRT.
The Estimator for Cluster 2, Period 4 is the Outcome
in the Upper Highlighted Box Compared to the Weighted
Mean of the Outcomes in the Lower Highlighted Box.
The Shading within the Lower Box Indicates 
Differential Weights.
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(c) Crossover Analysis Method for SW−CRT.
The Estimator for Period 4 is the Difference between
the Contrast of Outcomes in the Topmost Highlighted
Box and the Unweighted Mean of the Contrasts
of Outcomes in the Lower Highlighted Boxes.
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(d) Crossover−Synthetic Control Analysis Method
for SW−CRT. The Estimator for Period 4 is the Difference
between the Contrast of Outcomes in the Topmost High−
lighted Box and the Weighted Mean of the Contrasts of
Outcomes in the Lower Highlighted Boxes. The Shading
within the Lower Boxes Indicates Differential Weights.
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Figure 1: Schematic Representations of Several Existing and Novel Analysis Methods for a
SW-CRT with Seven Clusters, Eight Periods, and One Crossover Per Period. Dark Green
Boxes Indicate Cluster-Periods on Intervention and White/Gray Boxes Indicate Cluster-
Periods on Control.
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(a) Scenario 1. Common Time Effects, No Cluster−Period Effect
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(b) Scenario 2. Common Time Effecs, Cluster−Period Effect
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(c) Scenario 3. Varying Time Effects, No Cluster−Period Effect
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(d) Scenario 4. Varying Time Effects, Cluster−Period Effect
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Figure 2: Sample Generated Data for Four Risk Difference Scenarios (Simulation 1) with
No Treatment Effect. Each Line Represents the Simulated Cluster-Level Outcome for One
Cluster over Eight Time Periods.
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(a) Moderate Treatment Effect (β = −0.1)
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(b) No Treatment Effect (β = 0)
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Figure 3: Mean Treatment Effect Estimates and 1/2-Standard Deviation of Estimates across
1,000 Simulations for Risk Difference Scenarios (Simulation 1) by Analysis Method
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Figure 4: Type I Error Rate across 1,000 Simulations for Risk Difference Scenarios (Simula-
tion 1) by Analysis Method
29
(a) Moderate Treatment Effect (β = −0.1)
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(b) No Treatment Effect (β = 0)
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Figure 5: 95% Confidence Interval Coverage Rate across 1,000 Simulations for Risk Difference
Scenarios (Simulation 1) by Analysis Method
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Figure 6: Power across 1,000 Simulations for Risk Difference Scenarios (Simulation 1) with
Moderate Treatment Effect (β = −0.1) by Analysis Method
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(a) Scenario 1. Common Time Effects, No Cluster−Period Effect
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(b) Scenario 2. Common Time Effecs, Cluster−Period Effect
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(c) Scenario 3. Varying Time Effects, No Cluster−Period Effect
1 2 3 4 5 6 7 8
Period
Y i
j
0.
0
0.
2
0.
4
0.
6
0.
8
(d) Scenario 4. Varying Time Effects, Cluster−Period Effect
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Figure 7: Sample Generated Data for Four Odds Ratio Scenarios (Simulation 2) with No
Treatment Effect. Each Line Represents the Simulated Cluster-Level Outcome for One
Cluster over Eight Time Periods.
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(a) Moderate Treatment Effect (β = log(0.66) ≈  −0.416)
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(b) No Treatment Effect (β = log(1) = 0)
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Figure 8: Mean Treatment Effect Estimates and 1/2-Standard Deviation of Estimates across
1,000 Simulations for Odds Ratio Scenarios (Simulation 2) by Analysis Method
0% 5% 10% 15% 20% 25% 30% 35% 40% 45%
Type I Error
Common Time Effects
Varying Time Effects
ν=0
ν=0.01
ν=0
ν=0.01
MEM CPI NPWP SC−1 SC−2 CO−1 CO−2 CO−3 COSC ENS MEM−a CPI−a
Figure 9: Type I Error Rate across 1,000 Simulations for Odds Ratio Scenarios (Simulation
2) by Analysis Method
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(a) Moderate Treatment Effect (β = log(0.66) ≈  −0.416)
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(b) No Treatment Effect (β = log(1) = 0)
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Figure 10: 95% Confidence Interval Coverage Rate across 1,000 Simulations for Odds Ratio
Scenarios (Simulation 2) by Analysis Method
35% 40% 45% 50% 55% 60% 65% 70% 75% 80% 85% 90% 95% 100%
Power
Common Time Effects
Varying Time Effects
ν=0
ν=0.01
ν=0
ν=0.01
MEM CPI NPWP SC−1 SC−2 CO−1 CO−2 CO−3 COSC ENS MEM−a CPI−a
Figure 11: Power across 1,000 Simulations for Odds Ratio Scenarios (Simulation 2) with
Moderate Treatment Effect (β = log(0.66) ≈ −0.416) by Analysis Method
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Figure 12: Pairwise Covariance between Effect Estimates from Different Methods: Simula-
tion 1 (Risk Difference), Scenario 4, No Treatment Effect
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Figure 13: Pairwise Covariance between Effect Estimates from Different Methods: Simula-
tion 2 (Odds Ratio), Scenario 4, No Treatment Effect
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Appendices
A Proofs of theorems
Theorem 1. Suppose that for each cluster i, denoting by ji the last period for which cluster
i is on control, E[(Yi,1, Yi,2, . . . , Yi,ji)] = (Y·1, Y·2, . . . , Y·ji) ≡ Y·ji and that the distribution of
(Yi,1, Yi,2, . . . , Yi,ji) is symmetric about Y·ji. Suppose further that the cluster-level outcomes
from two different clusters are uncorrelated conditional on the full vector of expected out-
comes, Y·J , and the treatment effect β. Then, for any cluster i
∗ in any period j∗ where that
cluster is on intervention (j∗ > ji∗), the synthetic control estimator Zi∗,j∗ is an unbiased
estimate of the marginal (across clusters) expectation for an untreated cluster in period j∗.
That is, E[Zi∗,j∗] = Y·j∗.
Proof. Consider a target cluster i∗ and period j∗ such that Xi∗,j∗ = 1. Let m1, . . . , mn∗ index
the n∗ ≡ n0,j∗ clusters on control (“donor clusters”) in period j
∗. For any cluster i, define
Yi,ji∗ ≡ (Yi,1, . . . , Yi,ji∗)
T , where ji∗ is the last period for which cluster i
∗ is on control (and
thus ji∗ < j
∗). Denote the ji∗ × n
∗ matrix of pre-intervention donor cluster outcomes by
Y ≡
(
Ym1,ji∗ , . . . , Ymn∗ ,ji∗
)
. Construct a ji∗ ×n
∗ matrix of pre-intervention target cluster
outcomes by repeating the vector Yi∗,ji∗ n
∗ times: Yi∗ ≡
(
Yi∗,ji∗ , . . . , Yi∗,ji∗
)
.
By definition of the synthetic control estimator, Zi∗,j∗ =
∑n∗
n=1 vi∗,j∗,nYmn,j∗. The vector
of these weights is denoted vi∗,j∗ and lies in the set:
V ≡
{
v ∈ Rn :
n∗∑
n=1
vn = 1 ∩ 0 ≤ vn ≤ 1 ∀ 1 ≤ n ≤ n
∗
}
.
Note that for all v ∈ V, Yi∗v = Yi∗,ji∗ . Then we can write:
vi∗,j∗ = argmin
v∈V
‖Yi∗,ji∗ − Y v‖ = argmin
v∈V
‖(Yi∗ − Y )v‖ ≡ argmin
v∈V
∥∥∥Y diffi∗,j∗ v∥∥∥, (A1)
where the difference matrix is:
Y
diff
i∗,j∗ ≡ Yi∗ − Y =


Yi∗,1 − Ym1,1 Yi∗,1 − Ym2,1 . . . Yi∗,1 − Ymn∗ ,1
...
...
. . .
...
Yi∗,ji∗ − Ym1,ji∗ Yi∗,ji∗ − Ym2,ji∗ . . . Yi∗,ji∗ − Ymn∗ ,ji∗


=
(
Yi∗,ji∗ − Ym1,ji∗ . . . Yi∗,ji∗ − Ymn∗ ,ji∗
)
By the symmetry and independence assumptions, for any n = 1, . . . , n∗, Yi∗,ji∗ and Ymn,ji∗
are independent and both are symmetrically distributed with a common mean Y·ji∗ . Thus,
each column of Y diffi∗,j∗ is symmetrically distributed with expectation 0 and hence the matrix
Y
diff
i∗,j∗ is symmetrically distributed with expectation 0.
Moreover, for any n = 1, . . . , n∗, the distribution of Ymn,j∗ depends only on the nth
column of Y diffi∗,j∗ . Since
(
Ymn,1 − Y·,1, . . . , Ymn,j∗ − Y·j∗
)
is symmetrically distributed about(
0, . . . , 0
)
, the distribution of Ymn,j∗ − Y·j∗ conditional on Ymn,j∗ −Y·j∗ = (a1, . . . , aj∗) for
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any constants aj is equal to the distribution of −(Ymn,j∗−Y·j∗) conditional on Ymn,j∗−Y·j∗ =
(−a1, . . . ,−aj∗). Hence:
E[Ymn,j∗ − Y·j|Y
diff
i∗,j∗ = A] = −E[Ymn,j∗ − Y·j|Y
diff
i∗,j∗ = −A], (A2)
for any difference matrix A.
For any difference matrix A and any donor cluster mn, then:
E[Ymn,j∗|Y
diff
i∗,j∗ ∈ {−A,A}] = P [Y
diff
i∗,j∗ = A|Y
diff
i∗,j∗ ∈ {−A,A}]E[Ymn,j∗|Y
diff
i∗,j∗ = A]
+ P [Y diffi∗,j∗ = −A|Y
diff
i∗,j∗ ∈ {−A,A}]E[Ymn,j∗|Y
diff
i∗,j∗ = −A]
=
1
2
E[Ymn,j∗|Y
diff
i∗,j∗ = A] +
1
2
E[Ymn,j∗|Y
diff
i∗,j∗ = −A], by symmetry of Y
diff
i∗,j∗
= Y·j∗ +
1
2
(
E[Ymn,j∗ − Y·j∗|Y
diff
i∗,j∗ = A] + E[Ymn,j∗ − Y·j∗|Y
diff
i∗,j∗ = −A]
)
= Y·j∗ +
1
2
(0), by equation (A2)
= Y·j∗. (A3)
By equation (A1) and since
∥∥∥Y diffi∗,j∗ v∥∥∥ = ∥∥∥−Y diffi∗,j∗ v∥∥∥ for all v ∈ V, vi∗,j∗ is correlated with
the outcome vector (Ym1,j∗, Ym2,j∗, . . . , Ymn∗ ,j∗) only through the elementwise absolute
value of Y diffi∗,j∗ . Hence, for any n = 1, . . . , n
∗:
E[Ymn,j∗|vi∗,j∗] = E
[
E
[
Ymn,j∗|vi∗,j∗,Y
diff
i∗,j∗ ∈ {A,−A}
]∣∣∣vi∗,j∗]
= E
[
E
[
Ymn,j∗|Y
diff
i∗,j∗ ∈ {A,−A}
]∣∣∣vi∗,j∗]
= E [Y·j∗| vi∗,j∗] , by equation (A3)
= Y·j∗, since Y·j∗ is fixed. (A4)
And thus, denoting by vi∗,j∗,n the nth component of the vector vi∗,j∗ :
E[Zi∗,j∗] = E
[
n∗∑
n=1
vi∗,j∗,nYmn,j∗
]
= E
[
E
[
n∗∑
n=1
vi∗,j∗,nYmn,j∗
∣∣∣∣∣vi∗,j∗
]]
=
n∗∑
n=1
E [vi∗,j∗,nE [Ymn,j∗|vi∗,j∗]] =
n∗∑
n=1
E [vi∗,j∗,nY·j∗] , by equation (A4)
= Y·j∗E
[
n∗∑
n=1
vi∗,j∗,n
]
= Y·j∗ · 1 = Y·j∗, as desired. (A5)
Corollary 1. Suppose that for each control cluster-period (i, j), the individual outcomes
Yi,j,k are independent and identically distributed, conditional on the cluster and period, with
expectation Y ′i,j and finite variance. Suppose further that the Y
′
i,j values satisfy the conditions
in Theorem 1; that is, they are symmetrically distributed about some common expectation
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vector Y·J and each cluster’s values are independent of the values from all other clusters.
Then the synthetic control estimator Zi∗,j∗ for any cluster i
∗ in any period j∗ where that
cluster is on intervention is an asymptotically (with respect to the number of individuals in
each cluster) unbiased estimate of Y·j∗.
Proof. If the individual outcomes are independent and identically distributed with expec-
tation Y ′i,j and finite variance, then, by the Central Limit Theorem, the mean outcome Yi,j
for each control cluster-period is asymptotically (with respect to the number of individuals
in each cluster) normally distributed with expectation Y ′i,j and finite variance. Thus, for
any cluster i, we can write the distribution of the vector of pre-intervention cluster-level
outcomes, as:
(Yi,1, . . . , Yi,ji)
D
= (Y ′i,1, . . . , Y
′
i,ji
) + (Bi,1, . . . , Bi,ji) + op(1), (A6)
where Bi,j ∼ N(0, ξ
2
i,j) for some finite ξi,j, op(1)
P
→ 0, and the Bi,j are mutually independent.
Since the Bi,j are normally (and hence symmetrically) distributed, the limiting distribution
of (Yi,1, . . . , Yi,ji) is symmetric about (Y·1, . . . , Y·ji) by the assumption on Y
′
i,j. Moreover,
since the individual outcomes are independent conditional on the cluster-period mean and
the cluster means are independent by assumption, (Yi,1, . . . , Yi,ji) ⊥ (Yi′,1, . . . , Yi′,ji′ ) for any
i 6= i′.
Because of this asymptotic symmetry, for any target cluster-period (i∗, j∗) where Xi∗,j∗ =
1, for any difference matrix A:
lim
K→∞
P [Y diffi∗,j∗ = A|Y
diff
i∗,j∗ ∈ {A,−A}] = lim
K→∞
P [Y diffi∗,j∗ = −A|Y
diff
i∗,j∗ ∈ {A,−A}], and so
P [Y diffi∗,j∗ = A|Y
diff
i∗,j∗ ∈ {A,−A}] = 1/2 + o(1), (A7)
where limK→∞ o(1) = 0. Additionally, by this symmetry, for any donor cluster mn ∈
{m1, . . . , mn∗} (defined as in Theorem 1):
E
[
Ymn,j∗ − Y·j∗|Y
diff
i∗,j∗ = A
]
= −E
[
Ymn,j∗ − Y·j∗|Y
diff
i∗,j∗ = −A
]
+ o(1). (A8)
Thus, for any difference matrix A:
E
[
Ymn,j∗|Y
diff
i∗,j∗ ∈ {A,−A}
]
= P [Y diffi∗,j∗ = A|Y
diff
i∗,j∗ ∈ {A,−A}]E[Ymn,j∗|Y
diff
i∗,j∗ = A]
+ P [Y diffi∗,j∗ = −A|Y
diff
i∗,j∗ ∈ {A,−A}]E[Ymn,j∗|Y
diff
i∗,j∗ = −A]
=
(
1
2
+ o(1)
)(
E[Ymn,j∗|Y
diff
i∗,j∗ = A] + E[Ymn,j∗|Y
diff
i∗,j∗ = −A]
)
, by equation (A7)
=
(
1
2
+ o(1)
)(
2Y·j∗ + E[Ymn,j∗ − Y·j∗|Y
diff
i∗,j∗ = A] + E[Ymn,j∗ − Y·j∗|Y
diff
i∗,j∗ = −A]
)
=
(
1
2
+ o(1)
)
(2Y·j∗ + o(1)) , by equation (A8)
= Y·j∗ + o(1), by the properties of convergence.
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And so for any difference matrix A for any n = 1, . . . , n∗:
E
[
Ymn,j∗|Y
diff
i∗,j∗ ∈ {A,−A}
]
= Y·j∗ + o(1). (A9)
Following the steps in the proof of Theorem 1, and using the properties of convergence, then,
for any n = 1, . . . , n∗:
E [Ymn,j∗| vi∗,j∗] = Y·j∗ + o(1), (A10)
and thus, using that limK→∞ o(1) = 0:
lim
K→∞
E[Zi∗,j∗] = lim
K→∞
E
[
n∗∑
n=1
vi∗,j∗,nYmn,j∗
]
= lim
K→∞
(Y·j∗ + o(1)) = Y·j∗. (A11)
Hence, for any cluster i∗ and period j∗ where Xi∗,j∗ = 1, Zi,j is an asymptotically unbiased
estimate of Y·j∗.
Theorem 2. Assume that the assumptions of Theorem 1 are met and that for any in-
tervention cluster-period (i, j), E[Yi,j] = Y·j + β. Then for the risk difference function,
g(y1, y2) = y1 − y2, the synthetic control estimator βˆ with weights wi,j independent of the
outcomes is an unbiased estimate of β.
Proof. By Theorem 1, for any target cluster-period (i, j) such that Xi,j = 1, E[Zi,j] = Y·j
(note that we have dropped the i∗, j∗ notation for simplicity). Thus:
E
[
βˆ
]
= E

 ∑
(i,j):Xi,j=1
wi,j∑
(i,j):Xi,j=1
wi,j
βˆi,j

 = ∑
(i,j):Xi,j=1
E
[
wi,j∑
(i,j):Xi,j=1
wi,j
(Yi,j − Zi,j)
]
=
∑
(i,j):Xi,j=1
wi,j∑
(i,j):Xi,j=1
wi,j
E[Yi,j − Zi,j], since wi,j ⊥ Yi,j, Zi,j
=
∑
(i,j):Xi,j=1
wi,j∑
(i,j):Xi,j=1
wi,j
(Y·j + β − Y·j) =
∑
(i,j):Xi,j=1
wi,j∑
(i,j):Xi,j=1
wi,j
β = β. (A12)
Corollary 2. Assume that the assumptions of Corollary 1 are met and that for any in-
tervention cluster-period (i, j), E[Yi,j] = Y·j + β. Then for the risk difference function,
g(y1, y2) = y1 − y2, the synthetic control estimator βˆ with weights wi,j independent of the
outcomes is an asymptotically (with respect to the number of individuals in each cluster)
unbiased estimate of β.
Proof. By Corollary 1, for any target cluster-period (i, j) such thatXi,j = 1, limK→∞E[Zi,j] =
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Y·j (again dropping the i
∗, j∗ notation). Thus:
lim
K→∞
E
[
βˆ
]
= lim
K→∞
E

 ∑
(i,j):Xi,j=1
wi,j∑
(i,j):Xi,j=1
wi,j
βˆi,j


=
∑
(i,j):Xi,j=1
lim
K→∞
E
[
wi,j∑
(i,j):Xi,j=1
wi,j
(Yi,j − Zi,j)
]
=
∑
(i,j):Xi,j=1
wi,j∑
(i,j):Xi,j=1
wi,j
lim
K→∞
E[Yi,j − Zi,j], since wi,j ⊥ Yi,j, Zi,j, K
=
∑
(i,j):Xi,j=1
wi,j∑
(i,j):Xi,j=1
wi,j
(
lim
K→∞
E[Yi,j]− Y·j
)
=
∑
(i,j):Xi,j=1
wi,j∑
(i,j):Xi,j=1
wi,j
(Y·j + β − Y·j)
=
∑
(i,j):Xi,j=1
wi,j∑
(i,j):Xi,j=1
wi,j
β = β. (A13)
Thus βˆ is an asymptotically unbiased estimate of β.
Theorem 3. Assume that there is a constant risk difference β due to treatment across
clusters and periods; that is, E[Yi,j|Xi,j = 1] = E[Yi,j|Xi,j = 0] + β for all i,j. Then for
any weights wj that are independent of the outcomes Yi,j, the crossover estimators βˆ and β˜
using the risk difference function, g(y1, y2) = y1 − y2, are unbiased estimates of β. That is,
E[βˆ] = E[β˜] = β.
Proof. We denote by Y·j the expectation (marginal across clusters) of the outcome of any
cluster on control in period j. By the assumptions, for all j > 1:
E[Di,j|i ∈ I0,j] = E[Yi,j|Xi,j = 0]− E[Yi,j−1|Xi,j−1 = 0] = Y·j − Y·j−1. (A14)
E[Di,j|i ∈ I1,j] = E[Yi,j|Xi,j = 1]− E[Yi,j−1|Xi,j−1 = 0]
= E[Yi,j|Xi,j = 1]− E[Yi,j|Xi,j = 0] + E[Yi,j|Xi,j = 0]−E[Yi,j−1|Xi,j−1 = 0]
= β + Y·j − Y·j−1. (A15)
E[Di,j|i ∈ I2,j] = E[Yi,j|Xi,j = 1]− E[Yi,j−1|Xi,j−1 = 1]
= E[Yi,j|Xi,j = 1]− E[Yi,j|Xi,j = 0] + E[Yi,j|Xi,j = 0]
−E[Yi,j−1|Xi,j−1 = 0] + E[Yi,j−1|Xi,j−1 = 0]− E[Yi,j−1|Xi,j−1 = 1]
= β + Y·j − Y·j−1 − β = Y·j − Y·j−1. (A16)
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Define θ′j = Y·j − Y·j−1 for all j > 1. Then:
E[βˆj ] =
∑
i∈I1,j
1
n1,j
E[Di,j |i ∈ I1,j ]−
∑
i∈I0,j
1
n0,j
E[Di,j |i ∈ I0,j ]
=
n1,j
n1,j
(β + θ′j)−
n0,j
n0,j
(θ′j) = β. (A17)
E[β˜j ] =
∑
i∈I1,j
1
n1,j
E[Di,j |i ∈ I1,j ]−
∑
i∈I0,j
1
n0,j + n2,j
E[Di,j|i ∈ I0,j]
−
∑
i∈I2,j
1
n0,j + n2,j
E[Di,j|i ∈ I2,j]
=
n1,j
n1,j
(β + θ′j)−
n0,j
n0,j + n2,j
(θ′j)−
n2,j
n0,j + n2,j
(θ′j) = β. (A18)
Now, for any weights wj that are independent of the outcomes:
E[βˆ] = E
[∑
j>1
wj
w
βˆj
]
=
∑
j>1
wj
w
β, by equation (A17)
=
∑
j>1wj
w
β = β. (A19)
E[β˜] = E
[∑
j>1
wj
w
β˜j
]
=
∑
j>1
wj
w
β, by equation (A18)
=
∑
j>1wj
w
β = β. (A20)
So as desired, E[βˆ] = E[β˜] = β.
Corollary 3. Assume that there is a constant risk difference β due to treatment in the first
period on treatment across clusters; that is E[Yi,j|Xi,j = 1 ∩ Xi,j−1 = 0] = E[Yi,j|Xi,j = 0]+β
for all i, j. Then for any weights wj that are independent of the outcomes Yi,j, the crossover
estimator βˆ using the risk difference function, g(y1, y2) = y1− y2, is an unbiased estimate of
β. That is, E[βˆ] = β.
Proof. Again, we denote by Y·j the expectation (marginal across clusters) of the outcome of
any cluster on control in period j. By the assumptions, for all j > 1:
E[Di,j|i ∈ I0,j ] = E[Yi,j|Xi,j = 0]−E[Yi,j−1|Xi,j−1 = 0] = Y·j − Y·j−1. (A21)
E[Di,j|i ∈ I1,j ] = E[Yi,j|Xi,j = 1]−E[Yi,j−1|Xi,j−1 = 0]
= E[Yi,j|Xi,j = 1]−E[Yi,j|Xi,j = 0] + E[Yi,j|Xi,j = 0]
− E[Yi,j−1|Xi,j−1 = 0]
= β + Y·j − Y·j−1. (A22)
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Define θ′j = Y·j − Y·j−1 for all j > 1. Then:
E[βˆj ] =
∑
i∈I1,j
1
n1,j
E[Di,j|i ∈ I1,j ]−
∑
i∈I0,j
1
n0,j
E[Di,j|i ∈ I0,j ]
=
n1,j
n1,j
(β + θ′j)−
n0,j
n0,j
(θ′j) = β. (A23)
Now, for any weights wj that are independent of the outcomes, by equation (A23):
E[βˆ] = E
[∑
j>1
wj
w
βˆj
]
=
∑
j>1
wj
w
β =
∑
j>1wj
w
β = β. (A24)
So as desired, E[βˆ] = β.
Remark. Since E[βˆ] depends only on E[Di,j|i ∈ I1,j] and E[Di,j|i ∈ I0,j], it requires only the
weaker assumption of Corollary 3 to be unbiased, while E[β˜] requires the stronger assumption
given in Theorem 3.
Remark. Specifically, equal weighting and the weights wj and w
′
j given in Section 2.4.4 are
independent of the outcomes Yi,j and thus result in unbiased estimates if the other conditions
of Theorem 3 are met.
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B Variance and covariance of estimators
B.1 Simplified data-generating setting
Throughout this section, we assume that the underlying data-generating process for the
cluster-level outcomes follows a mixed-effects model:
Yi,j = µ+ αi + θj +Xi,jβ + ǫi,j (B1)
where the αi are independently distributed with mean 0 and variance τ
2, the ǫi,j are inde-
pendently distributed with mean 0 and variance σ2i,j and αi ⊥ ǫi′,j′ for all i, i
′, j′. Note that
this is similar to the risk difference model in Simulation 1 in Section 3, but differs in that
we force ǫi,j ⊥ αi, so the mean-variance relationship no longer holds.
Thus:
Var(Yi,j) = τ
2 + σ2i,j .
Cov(Yi,j, Yi′,j′) =
{
τ 2, i = i′, j 6= j′
0, i 6= i′
.
We assume, as in the simulations in Section 3, that there are J periods, J − 1 clusters,
with cluster i on control for periods 1, . . . , i and on intervention for periods i+ 1, . . . , J .
B.2 Variance of the non-parametric within-period estimator
The non-parametric within-period estimator is given by:
βˆNPWP =
J−1∑
j=2
vj
(∑j−1
i=1 Yi,j
j − 1
−
∑J−1
i=j Yi,j
J − j
)
≡
J−1∑
j=2
vjAj , (B2)
for weights vj that sum to 1. For ease of variance calculations, we here assume, contrary
to the estimator used Section 3, that the weights vj are fixed and independent of the data
(they can still depend on the number of clusters in the intervention and control conditions
in period j, however).
Var(Aj) = Var
(∑j−1
i=1 Yi,j
j − 1
−
∑J−1
i=j Yi,j
J − j
)
=
j−1∑
i=1
Var(Yi,j)
(j − 1)2
+
J−1∑
i=j
Var(Yi,j)
(J − j)2
=
∑j−1
i=1 (σ
2
i,j + τ
2)
(j − 1)2
+
∑J−1
i=j (σ
2
i,j + τ
2)
(J − j)2
=
J − 1
(J − j)(j − 1)
τ 2 +
∑j−1
i=1 σ
2
i,j
(j − 1)2
+
∑J−1
i=j σ
2
i,j
(J − j)2
.
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For j 6= k (WLOG, assume k > j):
Cov(Aj , Ak) = Cov
(∑j−1
i=1 Yi,j
j − 1
−
∑J−1
i=j Yi,j
J − j
,
∑k−1
i=1 Yi,k
k − 1
−
∑J−1
i=k Yi,k
J − k
)
=
1
(j − 1)(k − 1)
j−1∑
i=1
Cov(Yi,j, Yi,k)−
1
(J − j)(k − 1)
k−1∑
i=j
Cov(Yi,j, Yi,k)
+
1
(J − j)(J − k)
J−1∑
i=k
Cov(Yi,j, Yi,k)
= τ 2
(
1
k − 1
−
k − j
(J − j)(k − 1)
+
1
J − j
)
=
τ 2
(J − j)(k − 1)
(J − j − (k − j) + k − 1) = τ 2
J − 1
(J − j)(k − 1)
.
Thus:
Var(βˆNPWP ) = Cov
(
J−1∑
j=2
vjAj,
J−1∑
k=2
vkAk
)
=
J−1∑
j=2
v2jVar(Aj) + 2
J−2∑
j=2
J−1∑
k=j+1
vjvkCov(Aj , Ak)
=
J−1∑
j=2
v2j
[
J − 1
(J − j)(j − 1)
τ 2 +
∑j−1
i=1 σ
2
i,j
(j − 1)2
+
∑J−1
i=j σ
2
i,j
(J − j)2
]
+ 2
J−2∑
j=2
J−1∑
k=j+1
vjvkτ
2 J − 1
(J − j)(k − 1)
. (B3)
Note that the variance increases as any σ2i,j or τ
2 increase, holding all else constant.
B.3 Variance of the crossover estimator
The crossover estimator is given by:
βˆCO =
J−1∑
j=2
wj
[
Yj−1,j − Yj−1,j−1 −
1
J − j
J−1∑
ℓ=j
(Yℓ,j − Yℓ,j−1)
]
≡
J−1∑
j=2
wjBj , (B4)
for weights wj that sum to 1.
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Note that for all i, Yi,j − Yi,j′ = ǫij − ǫij′ + βI(Xij 6= Xij′). Hence:
Var(Bj) = Var
(
ǫj−1,j − ǫj−1,j−1 + β −
1
J − j
J−1∑
ℓ=j
(ǫℓ,j − ǫℓ,j−1)
)
= σ2j−1,j + σ
2
j−1,j−1 +
1
(J − j)2
J−1∑
ℓ=j
(σ2ℓ,j + σ
2
ℓ,j−1).
Cov(Bj, Bj+1) = Cov
(
ǫj−1,j − ǫj−1,j−1 + β −
1
J − j
J−1∑
ℓ=j
(ǫℓ,j − ǫℓ,j−1),
ǫj,j+1 − ǫj,j + β −
1
J − j − 1
J−1∑
m=j+1
(ǫm,j+1 − ǫm,j)
)
=
1
J − j
[
σ2j,j −
J−1∑
ℓ=j+1
σ2ℓ,j
J − j − 1
]
.
Cov(Bj , Bk) = Cov
(
ǫj−1,j − ǫj−1,j−1 + β −
1
J − j
J−1∑
ℓ=j
(ǫℓ,j − ǫℓ,j−1),
ǫk−1,k − ǫk−1,k−1 + β −
1
J − k
J−1∑
m=k
(ǫm,k − ǫm,k−1)
)
= 0 for k > j + 1.
Thus:
Var(βˆCO) = Cov
(
J−1∑
j=2
wjBj,
J−1∑
k=2
wkBk
)
=
J−1∑
j=2
w2jVar(Bj) + 2
J−2∑
j=2
wjwj+1Cov(Bj, Bj+1)
=
J−1∑
j=2
w2j
[
σ2j−1,j + σ
2
j−1,j−1 +
1
(J − j)2
J−1∑
ℓ=j
(σ2ℓ,j + σ
2
ℓ,j−1)
]
+ 2
J−2∑
j=2
wjwj+1
1
J − j
(
σ2j,j −
J−1∑
ℓ=j+1
σ2ℓ,j
J − j − 1
)
. (B5)
Note that, unlike the variance of the NPWP estimator, this variance does not depend on
τ 2.
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B.4 Covariance of the non-parametric within-period estimator and
the crossover estimator
We begin by noting that:
Aj =
1
j − 1
j−1∑
i=1
(µ+ αi + θj + β + ǫi,j)−
1
J − j
J−1∑
i=j
(µ+ αi + θj + ǫi,j)
= µ+ θj + β +
1
j − 1
j−1∑
i=1
(αi + ǫi,j)− (µ+ θj)−
1
J − j
J−1∑
i=j
(αi + ǫi,j)
= β +
1
j − 1
j−1∑
i=1
(αi + ǫi,j)−
1
J − j
J−1∑
i=j
(αi + ǫi,j).
Hence, dropping the β terms in Aj and Bj since they do not contribute any variability:
Cov(Aj , Bj) =
1
j − 1
j−1∑
i=1
Cov
(
αi + ǫi,j , ǫj−1,j − ǫj−1,j−1 −
1
J − j
J−1∑
ℓ=j
(ǫℓ,j − ǫℓ,j−1)
)
−
1
J − j
J−1∑
i=j
Cov
(
αi + ǫi,j , ǫj−1,j − ǫj−1,j−1 −
1
J − j
J−1∑
ℓ=j
(ǫℓ,j − ǫℓ,j−1)
)
=
1
j − 1
σ2j−1,j +
1
(J − j)2
J−1∑
i=j
σ2i,j.
Cov(Aj , Bk) =
1
j − 1
j−1∑
i=1
Cov
(
αi + ǫi,j , ǫk−1,k − ǫk−1,k−1 −
1
J − k
J−1∑
ℓ=k
(ǫℓ,k − ǫℓ,k−1)
)
−
1
J − j
J−1∑
i=j
Cov
(
αi + ǫi,j , ǫk−1,k − ǫk−1,k−1 −
1
J − k
J−1∑
ℓ=k
(ǫℓ,k − ǫℓ,k−1)
)
.
For j = k − 1:
Cov(Aj , Bk) =
σ2j,j
J − j
−
1
(J − j)(J − j − 1)
J−1∑
ℓ=j+1
σ2ℓ,j.
For j < k − 1 or j > k, Cov(Aj , Bk) = 0.
46
Therefore:
Cov
(
βˆNPWP , βˆCO
)
= Cov
(
J−1∑
j=2
vjAj,
J−1∑
k=2
wkBk
)
=
J−1∑
j=2
J−1∑
k=2
vjwkCov(Aj , Bk)
=
J−1∑
j=2
vjwj
[
1
j − 1
σ2j−1,j +
1
(J − j)2
J−1∑
i=j
σ2i,j
]
+
J−2∑
j=2
vjwj+1
[
σ2j,j
J − j
−
1
(J − j)(J − j − 1)
J−1∑
i=j+1
σ2i,j
]
. (B6)
Note that, like the variance of the crossover estimator, the covariance here does not
depend on τ 2.
B.5 Conditions for the ensemble estimator to have lower variance
If we moreover assume that σ2ij = σ
2 for all i, j, then:
Var(βˆNPWP ) = (τ 2 + σ2)
J−1∑
j=2
v2j
[
J − 1
(J − j)(j − 1)
]
+ 2τ 2
J−2∑
j=2
J−1∑
k=j+1
vjvk
J − 1
(J − j)(k − 1)
,
= (τ 2 + σ2)
J−1∑
j=2
v2j
(
1
j − 1
+
1
J − j
)
+ 2τ 2
J−2∑
j=2
J−1∑
k=j+1
vjvk
J − 1
(J − j)(k − 1)
.
Var(βˆCO) = 2
J−1∑
j=2
w2jσ
2
(
1 +
1
J − j
)
.
Cov(βˆNPWP , βˆCO) =
J−1∑
j=2
vjwjσ
2
(
1
j − 1
+
1
J − j
)
<
J−1∑
j=2
vjwjσ
2
(
1 +
1
J − j
)
.
Cov(βˆNPWP , βˆCO) =
J−1∑
j=2
vjwjσ
2
(
1
j − 1
+
1
J − j
)
< σ2
J−1∑
j=2
vjwj
(
1
j − 1
+
1
J − j
)
+ 2τ 2
J−2∑
j=2
J−1∑
k=j+1
vjvk
J − 1
(J − j)(k − 1)
.
If vj ≤ 2wj for all j = 1, . . . , n, then Cov(βˆ
NPWP , βˆCO) < Var(βˆCO). If σ2wj <
(τ 2 + σ2)vj for all j = 1, . . . , n, then Cov(βˆ
NPWP , βˆCO) < Var(βˆNPWP ).
Now consider the ensemble estimator βˆENS = 1
2
βˆNPWP + 1
2
βˆCO. Then:
Var(βˆENS) =
1
4
Var(βˆNPWP ) +
1
4
Var(βˆCO) +
1
2
Cov(βˆNPWP , βˆCO).
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So a necessary and sufficient condition for Var(βˆENS) < min
(
Var(βˆNPWP ), Var(βˆCO)
)
is:
2 Cov(βˆNPWP , βˆCO) < 3min
(
Var(βˆNPWP ), Var(βˆCO)
)
−max
(
Var(βˆNPWP ), Var(βˆCO)
)
.
For τ 2 = 0, Var(βˆNPWP < βˆCO) for some values of vj , wj , and σ
2 (e.g., for vj = wj for all
σ2). Take such a set of values of vj , wj, and σ
2. Then, since Var(βˆNPWP ) is an increasing
function of τ 2 and Var(βˆCO) is independent of τ 2, there is a τ 2 such that Var(βˆNPWP ) =
Var(βˆCO). So the condition simplifies to:
2 Cov(βˆNPWP , βˆCO) < 2 Var(βˆCO).
For vj ≤ 2wj for all j = 2, . . . , J−1, Cov(βˆ
NPWP , βˆCO) < Var(βˆCO). Hence, in this setting,
the ensemble estimator has a lower variance than either single estimator.
This suggests that when τ 2 is low enough that the crossover estimator and the non-
parametric within-period estimator to have similar variances, and the vj and wj are close
enough for the covariance to be lower than either of these variances, the ensemble method
has lower variance than either single estimator.
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C Goodness of fit of mixed effects models
Figure C1 provides two graphical displays of the goodness of the model fit: the quantile-
quantile plot of the standardized estimated random effects compared to a normal distribution
and the plot of residuals; both are shown for the risk difference (identity link) model, but
are similar for the odds ratio (logit link) model.
These figures suggest violations of the model assumptions, including potential non-
normality of the random effects. The Mahalanobis distance from the estimated random
effects to the normal distribution,59 however, is not significant at the 0.05 level. Common
goodness-of-fit tests applied to this distribution, such as the Kolmogorov-Smirnov, Anderson-
Darling, and Crame´r-von Mises tests,60 also yield non-significant results (all with p-values
above 0.65). The power of these tests to detect violations of the assumptions with a small
number of clusters can be quite low, however.61
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Figure C1: Diagnostics for Mixed Effects Models for Tuberculosis SW-CRT
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